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ABSTRACT 
P2Y receptors are expressed in apical and/ or basolateral membranes of 
virtually all polarized epithelia to control the transport of fluid and electrolytes. In the 
airway, CI" secretion and Na+ reabsorption can be modulated by activation of multiple 
P2Y receptors, which couple to the phospholipase C and calcium signaling pathways. 
Coordinated regulation of CI" secretion and Na+ reabsorption is important to maintain 
the thickness and the composition of airway surface liquid, which in turn affects 
airway mucus clearance. The aim of the present study is to examine the effect of 
extracellular nucleotides such as ATP, UTP and UDP on basal short-circuit current 
(Isc) and intracellular calcium release ([Ca^ "^ ],) in a human bronchial epithelial cell 
line (16HBE14o-) and to characterize the signal transduction pathways that allow P2Y 
receptors to regulate electrolyte transport. 
Cells were maintained in culture using standard techniques and grown on 
Transwell-COL membranes until confluent. Isc and [Ca^^], were measured 
simultaneously by electrophysiological and microspectrofluorometric methods, 
respectively. Epithelia were mounted in miniature Ussing chambers where the cells 
were perfused bilaterally with normal Krebs-Henseleit (KH) solution. To generate a 
favorable gradient for CI" exit, a basolateral to apical CI" gradient was applied across 
the epithelia by changing the apical KH solution with reduced CI" concentration (10 
mM). To examine the sidedness of functional P2Y receptor expression, the epithelia 
were stimulated with either apical or basolateral application of ATP, UTP and UDP. 
In general, all P2Y agonists stimulated an increase in Isc, which was 
accompanied by a concomitant increase in [Ca^^],. Apical nucleotides apparently were 
more efficacious than basolateral nucleotides in stimulating [Ca^ "^ ], increase. However, 
the effects on Isc were more prominent when P2Y agonists (except for UDP) were 
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added on the basolateral aspect of the epithelia. The regulatory pathway(s) underlying 
the asymmetric effects of nucleotides on Isc and [Ca^^], remains to be elucidated. It 
has been suggested that UDP, a specific agonist for P2Y6 receptor, may couple to both 
Ca2+- and cAMP-dependent CI" secretion in epithelia. Therefore, in the present study, 
the function of P2Y6 receptors in human bronchial epithelia was further investigated 
by using specific CI" or K+ channel blockers. In addition, the involvement of PKA and 
PKC upon the apical or basolateral effect of UDP was also examined. 
The Isc induced by apical UDP was blocked by CFTRinh-172 (10 |iM), a 
specific blocker of cystic fibrosis transmembrane conductance regulator (CFTR); 
DIDS (500 }iM), a selective blocker of Ca '^^ -activated CI" channel; clotrimazole (100 
laM), a blocker of intermediate-conductance Ca^^-activated K+ (IKCal) channel; and 
TRAM-34 (10 |iM), a more potent and selective blocker of IKCal channel; whereas 
the apical UDP-evoked Isc was insensitive to chromanol 293B (10 |iM), a specific 
blocker of cAMP-dependent K+ channel. Similar effects of ion channel blockers were 
observed on basolateral UDP-evoked Isc, except that this Isc response was insensitive 
« 
to CFTRinh-172. Both apical and basolateral application of UDP increased the PKA 
activity in cells. GF109203x (5 ^M), a specific but broad spectrum inhibitor of PKC 
isozymes, had no effect on the apical and basolateral effect of UDP. 
In summary, our data demonstrate that apical and basolateral P2Y agonists 
stimulated a Ca '^^ -dependent CI" secretion in concentration-dependent manner across 
human bronchial epithelia, which expressed multiple functional P2Y receptors. The 
data are consistent with our earlier molecular study using quantitative real-time PCR, 
which suggests the expression of mRNA coding for P2Yi, P2Y2, P2Y4 and P2Y6 
receptor subtypes. Additionally, our data show that PKA but not PKC was involved in 
the modulation of CI" secretion mediated by P2Y6 receptors. Presumably, apical P2Y6 
receptors may be coupled to both cAMP- and Ca^^-dependent pathways while 
vi 
basolateral P2Y6 receptors may only be coupled to Ca^^-dependent pathway. These 
data could have implications for the regulation of transepithelial CI" secretion which 
enable the development of new therapies for airway diseases associated with defects 































(10 mM)；特異性躬激活性氯通道阻斷劑DIDS (500 MM)；特異性躬激活性鉀通道 
阻斷劑clotrimazole (100 pM)以及特異性更強的韩激活性鉀通道阻斷劑TRAM-34 
(10 mM)均能減低由施加於細胞頂膜的二磷酸尿苷所引起的短路電流；反之’特 
異性cAMP激活性钟通道阻斷劑chromanol 293B (100 mM)則對此短路電流沒有影 
響。另一方面’除了 CFrRinh-172及chromanol 293B對由施加於細胞基側膜的二 
碟酸尿苷所弓丨起的短路電流沒有影響之外，其餘的通道阻斷劑均能減低此短路電 
流。此外，施加於細胞頂膜以及細胞基側膜的二磷酸尿苷都增強了細胞中蛋白致 
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1.1 Regulation of human airway surface liquid 
Human airway is lined mostly by ciliated epithelium. The airway epithelium is 
bathed by airway surface liquid (ASL). The thickness and composition of ASL is of 
great importance in airway mucus clearance (Matsui et al., 1998; Tarran et al., 2001). 
ASL is separated into a periciliary liquid layer (PCL) and a mucous layer lying above 
PCL (Lucas & Douglas, 1994) (Fig. 1.1). The depth of PCL is strictly regulated to a 
height that approximates the length of outstretched cilia in order to facilitate the 
ciliary beating, by which mucous can be removed efficiently. Depletion of PCL 
impedes the beating action of cilia, and subsequently impairs the mucociliary 
clearance (Pilewski & Frizzell，1999). The accumulation of mucous on airway surface 
consequently leads to airway obstruction and bacterial infection (Matsui et al., 1998; 
Tarran et a/.�2001). 
A balance between absorption and secretion of ions and fluid in airway 
epithelia is important to maintain the volume and composition of PCL. Active and 
passive ion and water transport across the airway epithelial cells are regulated by 
well-coordinated actions of ion channels, pumps as well as transporters in cells. 
Therefore, defects in ion transport functions of airway cells can affect PCL and thus 
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Figure 1.1 The composition of airway surface liquid bathing airway epithelium. 
ASL (airway surface liquid); PCL (periciliary liquid). (Modified from Boucher, 
2003) 
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1.2 Sodium reabsorption and chloride secretion in airway epithelium 
Airway epithelia, especially the upper airways, can both absorb and secrete 
ions and fluid. A balance between absorption and secretion is important in 
maintaining the thickness and viscosity of airway surface liquid lining the airway 
epithelia. Channels mediating Na+ transport mainly account for the Na+ reabsorption 
across the epithelium. Na+ enters cells across the apical membrane via 
amiloride-sensitive epithelial Na channels (ENaC) (Garty & Palmer, 1997). The Na+ 
entering cells is extruded by Na+-K+-ATPase. K+ accumulated by the pump is then 
recycled through basolateral K+ channels (Boucher, 1994). Figure 1.2 shows a 
schematic cellular model for Na+ reabsorption. 
On the other hand, transepithelial CI" secretion occurring in airway epithelial 
cells is mainly dependent on two types of ion channels, apical CI" channels and 
basolateral K+ channels (Welsh, 1987). Electroneutral Na+-K+-2Cr cotransporter 
(NKCC) is present in the basolateral membrane in parallel with the Na+-K+-ATPase. 
The NKCC performs secondary-active CI" uptake, which allows CI" to be accumulated 
above electrochemical equilibrium across the basolateral membrane. Thus, CI" exits 
the cells by electrodiffusion across the apical membrane through CI" channels. The 
Na+ and IC+ entering the cells is recycled through basolateral Na+-K+-ATPase and K+ 
channels, respectively. The extrusion of K+ also serves to hyperpolarize the cell, 
thereby maintaining the driving force for CI" exit across the apical membrane (Smith 
& Frizzell, 1984; Willumsen et al” 1989). Notably, many studies have reported the 
involvement of purinergic receptors in the regulation of CI" secretion in airway 
epithelial cells (Knowles et al, 1991; Mason et al, 1991; Homolya et al, 1999; Inglis 
et al, 1999). Figure 1.3 illustrates an example of a simplified model of apical P2Y2 
receptor-mediated ion transport regulation in airway epithelial cells. Basolateral K+ 
Introduction 4 
channels are also shown to be involved in the regulation of CI" secretion mediated by 
P2Y receptors in airway cells (Clarke et aL, 1997). 
Introduction 5 
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Figure 1.2 Schematic cellular model for Na+ reabsorption. ENaC refers to 
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Figure 1.3 Schematic model of apical P2Y2 receptor-mediated ion transport 
regulation in airway epithelial cells. Apical ATP/UTP stimulates the CI" channels 
and thus CI" secretion. CI" secretion requires Na+-K+-2C1- cotransporter 
(NKCC)-mediated, secondarily active CI" uptake on the basolateral side and 
-J I 
extrusion of CI" via either apical CFTR or Ca -activated CI" channels. (Adapted 
from Leipziger, 2003) 
Introduction 7 
1.3 Purinergic receptors 
Purinergic receptors are ubiquitous transmembrane receptors which have been 
subdivided into two major classes, PI and P2 receptors. PI receptors are mainly 
activated by adenosine while P2 receptors are activated by extracellular nucleotides 
such as ATP, ADP, UTP and UDP. These receptors signal through a variety of 
intracellular signaling pathways and play an important role in mediating ion transport 
in epithelial cells. Figure 1.4 gives an overview of these receptors and their role in 
regulation of ion transport. 
The PI receptors are a family of G protein-coupled receptors in response to 
nucleoside activation, primarily with adenosine. PI signaling is complex in which 
multiple intracellular effectors are involved. The four subtypes of PI receptors, 
namely, Ai, A2a, A2b and A3 have their unique roles in different epithelial tissue types 
(Bucheimer & Linden, 2004). 
There are two types of P2 receptors, namely metabotropic (G protein-coupled) 
P2Y receptors and ionotropic P2X receptors. They are expressed in all tissues and 
induce a variety of biological effects. In epithelia, they are found in both apical and 
basolateral membranes (Leipziger, 2003). Multiple isoforms of P2Y and P2X 
receptors are found, including eight known P2Y receptor subtypes (P2Yi, P2Y2, P2Y4, 
P2Y6,P2Yii, P2Yi2, P2Yi3 and P2Y14) and eight P2X receptor subtypes (P2X1.7 and . 
P2XM) (Bucheimer & Linden, 2004). P2Y receptors are activated by extracellular 
nucleotides such as ATP, ADP, UTP and UDP. P2Y receptor subtypes respond 
differentially and selectively to specific diphosphate or triphosphate nucleotides 
(Fredholm et al, 1994; Harden et al, 1997). Their preferences for naturally occurring 
ligands are shown in Table 1 (King et al, 2001; Communi et al., 2001). P2X receptors 
are ligand-gated channels in response to ATP as well as 2-MeSATP (Khakh et al, 
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2001). Their activation increases the permeability of plasma membrane to cations, 
specifically, Na+ or Ca2+. 
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Figure 1.4 The roles of Purinergic receptors in regulating epithelial ion transport. 
The PI receptors are usually coupled to Gs or Gj/o proteins, signaling through 
multiple intracellular effectors in response to nucleoside activation. P2X receptors 
are ligand-gated ion channels and increase cell permeability to Na+ or Ca^ "^ . P2Y 
receptors classically signal through Gq, resulting in an increase in intracellular 
Ca2+ and activation of Ca^^-dependent CI" and K+ channels, although a Ca^^ 
independent CI" current resulting from P2Y activation has been identified. 
(Adapted from Bucheimer & Linden, 2004) 
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Table 1 Natural ligands for P2Y receptors (Bucheimer & Linden, 2004) 
Receptors Preferred natural agonists 
P2Yi ADP>ATP 
P2Y2 UTP = ATP 





P2Yi4 UDP-glucose > UDP-galactose > UDP-N-acetylglucosamine 
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1.4 P2Y receptors in epithelial cells 
Epithelial cells line the inside of internal organs such as lung, kidney and 
gastrointestinal tract and form a barrier between the external environment and the 
underlying cells. Tight junction is an essential component for intercellular connection 
in the epithelia. It governs the paracellular permeability of the epithelia to create a 
functional barrier to regulate the flux of ions or fluid in paracellular space. On the 
other hand, tight junction helps to separate the cell membrane into two structurally 
and functionally distinct membrane domains in polarized cells. Cell surface lies above 
tight junction is termed as apical surface while cell surface lies below tight junction is 
termed as basolateral surface (Yeaman et al, 1999). The differential expression of 
different receptor proteins between apical and basolateral membranes enables the 
polarized cells to regulate a wide range of cellular activities precisely. 
In recent years, a number of essential steps forward were made on the study of 
P2 receptors. The airway epithelium was discovered to have a dominant expression of 
P2 receptors (Knowles et al, 1991; Mason et al, 1991). Generally, activation of P2 
receptors regulates ion transport in airway epithelium by activating NaCl secretion 
(Homolya et al, 1999; Inglis et al, 1999; Mason et al, 1991) as well as inhibiting 
electrogenic Na+ reabsorption (Devor & Pilewski, 1999; Inglis et al, 1999; Mall et al, 
2000), which results in an increased hydration of airway surface liquid and thus the 
activation of mucociliary clearance (Lethem et al, 1993). 
Specifically, in airway epithelial cells, the predominantly expressed P2 
receptors are P2Y receptors (Bucheimer & Linden, 2004). On the other hand, P2Y 
receptors, when compared with P2X receptors, are found to play a more important 
role in airway epithelia (Paradise et al, 1995; Wilson et al, 1998). For example, 
Cressman et al. (1999) demonstrated that in P2Y2 receptor-deficient mice, there was a 
Introduction 12 
lost of 85 - 95% of the nucleotide-stimulated CI" secretion in their airway cells. 
To date, eight functional human P2Y receptor subtypes, namely P2Yi, P2Y2, 
P2Y4, P2Y6, P2Y,,, P2Yi2, P2Yi3, and P2Yi4, have been characterized by molecular 
cloning and pharmacological studies. P2Y receptors belong to the G protein-coupled 
receptor superfamily (Ralevic & Bumstock, 1998). In general, P2Y receptors are 
coupled to Gq protein, which upon stimulation, activate phospholipase C to generate 
inositol 1,4,5-trisphosphate and promote calcium signaling (Ralevic & Bumstock, 
1998). Apart from Gq protein, P2Yii receptors are coupled to Gs protein which in turn 
stimulate adenylyl cyclase (Communi et al” 1997; Qi et al, 2001; Torres et al, 2002) 
whereas P2Yi2, P2Yi3, and P2Yi4 receptors activate Gj,�protein to promote the 
inhibition of adenylyl cyclase activity (Chambers et al, 2000; Communi et al” 2001; 
Hollopeter et al., 2001; Zhang et al, 2002). 
Multiple studies showed that P2Y receptor subtypes are expressed in 
epithelial cells from various tissues (Cressman et al, 1999, Homolya et al, 1999; 
Leipziger, 2003; Marcus & Scofield, 2001; Post et al, 1998; Robaye et al, 2003; 
Wong & Ko, 2002; Zambon et al, 2001; Zambon et al, 2000) and on the other hand, 
these epithelial cells themselves express multiple subtypes of P2Y receptors (Post et 
al, 1996). These studies highlight the prominent role of extracellular nucleotides in 
the regulation of a broad range of epithelial cell function, at which extracellular 
nucleotides are the natural agonists of P2Y receptors. 
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1.5 Autocrine or paracrine regulation of ion transport in epithelial cells 
A number of studies reported that mechanical stimulation induces the release 
of endogenous adenine and uridine nucleotides from airway epithelial cells 
(Lazarowski et al, 1997; Watt et ai, 1998; Homolya et al, 2000). On the other hand, 
it is demonstrated that upon the application of ATP and UTP to the apical surface of 
airway cells, a Ca^^-activated CI" secretion is observed (Mason et al, 1991; 
Lazarowski et al, 1997; Homolya et al, 1999). Therefore, the G protein-coupled P2Y 
receptors may have an important role in the autocrine and paracrine regulation of ion 
transport in airway epithelia. 
Various kinds of stimuli including mechanical stimuli, cell swelling, and 
inflammatory stimuli have been shown to trigger the release of nucleotides from cells. 
(Taylor et al., 1998; Roman & Fitz, 1999; Harden & Lazarowski, 1999). Usually, 
nucleotides are released at concentrations sufficient to stimulate P2Y receptors. The 
presence of membrane-associated ecto-enzymes precisely mediates and terminates the 
action of extracellular nucleotides (Zimmermann et al, 2000). The released 
nucleotides, for example, ATP, activates its corresponding P2Y receptor subtype. On 
the other hand, ATP is converted by ecto-enzymes to ADP and AMP, which in turn 
activates other P2Y receptor subtypes (Zimmermann, 1996). In particular, AMP is 
further converted to adenosine by ecto-5'nucleotidase. Adenosine then activates PI 
receptors. Thus, the released nucleotides as well as their subsequent metabolites, 
specifically ATP, ADP, UTP, UDP, UDP-glucose and adenosine activate multiple P2Y 
receptor subtypes which are coupled to multiple purinergic signaling to regulate ion 
transport across the epithelial cells effectively. The interplay between nucleotides 
release, nucleotide metabolism and activation of purinergic receptors is summarized 
in Figure 1.5. 
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This extracellular nucleotide action is of physiological significance. It serves 
as the principal natural defense system of airways that protects cells from adverse 
situations (Lazarowski & Boucher, 2001; Leipziger, 2003). For example, the 
inhalation of foreign particles or cough stimulates nucleotide release into the airway • 
surface liquid, and subsequently activates P2Y receptors to stimulate Ca^^-activated 
Cr secretion and initiates the machinery of mucociliary clearance (Lazarowski & 
Boucher, 2001). 
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Figure 1.5 Interplay of released nucleotides, nucleotide metabolism, and activity 
of P2Y, P2X, and PI receptors. Released ATP, UTP, and UDP-glucose activate 
P2Y2, P2Y4, P2Yii, or P2Yi4 receptors and ATP activates all P2X receptors. 
Ecto-nucleotidases generate ADP and UDP, which in turn lead to P2Yi and P2Y6 
receptor activation, respectively. Adenosine, the final product of adenine 
nucleotide hydrolysis, activates PI receptors, (Adapted from Lazarowski et al, 
2003) 
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1.6 Signaling pathways underlying the regulation of ion transport by P2Y 
receptors stimulation 
Extracellular nucleotides exert their actions on epithelial cells by binding to 
P2Y receptors which in turn are coupled to multiple signal transduction pathways 
within the cells. Stimulation of P2Y receptors lead to the dual activation of both 
phospholipase C (PLC) and adenylate cyclase (AC) (Son et al, 2004). 
On one hand, the heterotrimeric Gq protein-coupled P2Y receptors activate 
PLC, by which inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) are 
generated from phosphatidylinositol 4,5-diphosphate (PIP2). IP3 diffuses into the 
cytosol and bind to specific receptors through which it mobilizes intracellular calcium 
stores (Taylor & Richardson, 1991; Marshall & Taylor, 1993). Increase in intracellular 
calcium concentration ([Ca^^],) in turn activates Ca^^-dependent CI" or K+ channels. 
Meanwhile, the formation of DAG accumulated in the cytoplasm leads to the 
activation of protein kinase C. Studies suggested that PKC activation may principally 
regulate human airway secretion via interactions with cystic fibrosis transmembrane 
conductance regulator (CFTR) (Jia et al, 1997; Liedtke & Cole, 1998). PKC 
phosphorylated sites have been identified in CFTR (Picciotto et al, 1992). It is 
diagrammatically described in Figure 1.6，A. 
On the other hand, stimulation of P2Y receptors also activates adenylate 
cyclase (AC), resulting in an increase in cAMP production (Fig. 1.6, B). cAMP in turn 
activates protein kinase A (PKA) by which it stimulates the activity of 
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Figure 1.6 Cell model showing the regulation of ion channels in response to P2Y 
receptor stimulation. A: A schematic diagram showing the regulation of CI" 
secretion in response to apical P2Y receptor stimulation, signaling through the 
activation of PLC-mediated pathway; B: A hypothesized scheme of the other 
regulatory pathway involved in CI" secretion mediated by apical and basolateral 
P2Y receptors; (+) indicates stimulatory effects. The P2Y receptors also couple 
with adenylate cyclase (AC), by which the AC-mediated pathway linking to the 
cAMP-PKA transduction activates the cAMP-dependent CI" channel CFTR on the 
apical membrane. (Adapted from Palmer et al, 2006; Son et al, 2004, 
respectively) 
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1.7 The therapeutic potential of P2Y receptors in treating cystic fibrosis 
Cystic fibrosis (CF) is an inherited disease characterized by the lack of cAMP-
regulated CI" channel (CFTR) activity in the apical membrane of affected epithelia 
(Quinton, 1990). In airway, the CFTR defect leads to a decrease in the airway surface 
liquid (ASL) covering the epithelia and thickened mucus secretions that severely 
impair mucociliary clearance, thus promoting lung infections (Matsui et al, 1998). 
One important effect of nucleotides on the airway epithelium is an increase in 
the apical permeability to CI" (Communi et al, 1999) which helps to improve the 
hydration of airway surface of cystic fibrosis patients and thus increases the efficiency 
of airway mucus clearance. Since nucleotide activation of CI" secretion is mainly 
mediated by P2Y receptors, P2Y receptors are of therapeutic interest in treating cystic 
fibrosis and thus they have been studied extensively in the airway epithelium in recent 
years. 
As mentioned before, P2Y receptors are Gq protein-coupled receptors. Upon 
stimulation, P2Y receptors activate phospholipase C and downstream effectors which 
lead to the increase in intracellular calcium concentration and activate the Ca^^-
dependent CI" channels. Boucher et al (1989) reported that this Ca^"^-mediated CI" 
secretion is preserved in human CF tissues. Moreover, other studies showed that 
stimulation of P2Y receptors activate the Ca^^-dependent K+ channels and meanwhile 
inhibit electrogenic Na+ absorption, and finally result in an increased CI' secretion 
(Mason et al, 1991; Clarke et al, 1997; Inglis et al, 1999; Leipziger, 2003). Thus, it 
is noteworthy that the regulation of CI" secretion mediated by P2Y receptors involves 
the Ca2+-dependent pathways but does not necessarily involve the cAMP-dependent 
CFTR Cr channel, suggesting that the nucleotide-stimulation of CI" secretion may 
serve to bypass the secretory defect in cystic fibrosis patients (Leipziger, 2003). 
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More importantly, studies revealed that the Ca^^-activated CI" secretions are 
upregulated in human CF airway epithelia (Knowles et al, 1991; Paradise et al, 
2001). These suggest that the lack of the cAMP-dependent CI" secretion in CF patients 
can be compensated by the alternative Ca '^^ -dependent CI" secretion (Fig. 1.7)，as a 
result of the extracellular nucleotide-activation of P2Y receptors. This is of 
therapeutic significance in overcoming the CI" secretion defect in cystic fibrosis. 
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Figure 1.7 Model for apical P2Y receptor activation of CI" secretion in normal and 
cystic fibrosis (CF) human airway epithelia. P2Y-R (P2Y receptor); Gq 
(heterotrimeric GTP-binding protein); PLC (phospholipase C); IP3 (inositol 
1,4,5-triphosphate); Ca^ "" (intracellular Ca^^); AC (adenylate cyclase); CFTR 
(cystic fibrosis transmembrane conductance regulator); and CaCC (Ca^^-activated 
Cr channel). (Modified from Paradiso et al, 2001) 
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1.8 Particular interest on P2Y6 receptor as potential target for treatment of cystic 
fibrosis 
ATP and UTP were equipotent and subject to degradation to ADP and UDP by 
ecto-enzymes, respectively. As a potential therapeutic target, pyrimidine nucleotides 
seem preferable, since they are not degraded to adenosine which induces 
bronchoconstriction (Communi et al, 1999; Schreiber & Kunzelmann, 2005). 
According to Lazarowski et al. (1997), UDP is more stable than UTP in cells. UTP is 
hydrolysed at a 2- to 3-fold faster rate than UDP, and consequently, UDP accumulates 
on the cell surface after the breakdown of UTP, suggesting that UDP may potentially 
serve as a more stable and important signaling molecule in human airway tissue. 
UDP is a potent and selective agonist of P2Y6 receptor subtype (Nicholas et 
al, 1996). The presence of P2Y6 receptors have been reported in human nasal 
epithelial cells (Lazarowski et al, 1997), human bronchial epithelial cells (Communi 
et al, 1999), rat colonic epithelial cells (Kottgen et al, 2003) and in mouse trachea 
(Schreiber & Kunzelmann, 2005). Notably, Kottgen et al (2003) showed that UDP 
stimulated a sustained CI" secretion which was synergistically mediated by two 
2+ 
independent intracellular second messengers, cAMP and [Ca ],. On the other hand, 
Schreiber & Kunzelmann (2005) demonstrated that luminal UDP induced Ca^^- and 
cAMP-dependent CI" secretion in mouse trachea. These studies have made P2Y6 
receptors as potential therapeutic target in treating cystic fibrosis. 
In contrast to other P2Y receptor subtypes, P2Y6 receptors may be of higher 
therapeutic values. It is believed that activation of P2Y6 receptors in the airways is 
capable of shifting electrolyte transport towards secretion by increasing both 
intracellular Ca^ "^  and cAMP. In addition, when comparing with ATP/UTP-stimulated 
P2Y2 receptors, the parallel activation of both intracellular pathways mediated by 
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UDP-stimulated P2Y6 receptors may serve to promote more powerful and longer 
lasting c r secretion in cystic fibrosis patients (Schreiber & Kunzelmann, 2005). 
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1.9 Properties of 16HBE14o- cell line 
The 16HBE14o- cell line has been immortalized from the human bronchial 
epithelial cells (Cozens et al., 1994). It affords easy maintenance with high 
reproducibility. 16HBE14o- cells form polarized monolayers that are comparable with 
bronchial epithelia in vivo. They retain differentiated epithelial morphology on which 
microvilli and cilia can be detected. Immunofluorescence staning and electron 
microscopy showed that these cell layers form well-defined tight, adherens, and gap 
junctions, and highly organized actin filaments (Ehrhardt et al, 2002). The presnece 
of tight junctions indicated that directional ion transport property is retained in 
16HBE140- cells (Welsh & Liedtke, 1986; Rechkemmer, 1988). 
Amiloride, an inhibitor of epithelial sodium channel (ENaC), exerted no 
significant effect on either the baseline properties or the agonists-induced short-circuit 
current of 16HBE14o- cells (Koslowsky et al, 1994). Since no sodium transport 
could be detected in 16HBE14o- cells, it was likely that the observed conductance 
was due to CI" secretion (Bernard et al, 2003). In this sense, 16HBE14o- cells enable 
direct measurement of CI" secretion and thus the study of the underlying mechanism 
‘ in Cr secretion. 
16HBE140- cells express high levels of CFTR mRNA and protein (Cozens et 
aL, 1994). More than that, molecular study of P2Y receptors in 16HBE14o- cells had 
characterized the expression of P2Y2, P2Y4 and P2Y6 receptor subtypes in this cell 
line (Communi et al., 1999). Taken together, these allow the study of the role of 
CFTR as well as P2Y receptor subtypes in regulation of chloride ion transport in 
human airway epithelia. In short, 16HBE14o- cell line appears to be a good model to 
study the mechanisms underlying the regulation of bronchial epithelial cell function 
(Ehrhardt et al, 2002). 
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16HBE14o- cells were grown as polarized epithelia on permeable Transwell-
COL membrane supports in liquid-covered condition. Studies showed that epithelial 
cells cultured in this way can closely mimic in vivo cell morphology and enable drugs 
or reagents to access both apical and basolateral aspects of polarized epithelia (Matsui 
et al, 1998; Ehrhardt et al, 2002). 
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1.10 Objectives of the present experiments 
As discussed above, coordinated regulation of CI" secretion is important to 
maintain the thickness and composition of airway surface liquid, which in turn affects 
airway mucus clearance (Tarran et al, 2006). In the airway, CI" secretion is modulated 
by activation of multiple P2Y receptors expressing in apical and/or basolateral 
epithelial membrane (Leipziger, 2003). 
Thus, the present study aims to examine the effect of extracellular nucleotides 
(P2Y agonists) on basal short-circuit current {Isc) as well as intracellular calcium 
concentration ([Ca^ "^ ],) in a human bronchial epithelial cell line (16HBE14o-) and to 
characterize the signal transduction pathways that allow P2Y receptors to regulate 
electrolyte transport. Furthermore, we investigate the effect of UDP on chloride 
secretion, and the underlying ionic mechanism upon the activation of P2Y6 receptors. 
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CHAPTER I I 
MATERIALS AND METHODS 
2.1 Solutions and Chemicals 
Normal Krebs-Henseleit solution (KH solution) contained (in mM): 2.56 
CaCb, 117 NaCl, 4.7 KCl, 1.2 MgCb, 1.2 KH2PO4, 24.8 NaHCOs, and 11.1 
D-glucose. Low CI" KH solution was prepared by 20 Ca-gluconate, 10 NaCl, 107 
Na-gluconate, 4.7 K-gluconate, 1.2 MgS04, 1.2 KH2PO4, 24.8 NaHCOs, and 11.1 
D-glucose. The solutions were continuously bubbled with 95% O2 and 5% CO2 to 
maintain the pH at 7.4 during all experiments. 
UTP (uridine triphosphate), UDP (uridine diphosphate), DIDS (disodium 4,4'-
diisothiocyanatostilbene-2,2'-disulfonate), clotrimazole (1 -(oChloroa,adiphenylben-
zyl)imidazole) and TRAM-34 (1 -[(2-Chlorophenyl)diphenylmethy 1]-1 H-pyrazole) 
were from Sigma (St Louis, MO, USA). 
Before use, UDP (10 mM) was incubated (1 h at 37°C) in normal KH solution 
containing hexokinase (100 U/ml, Roche, Indianapolis, IN, USA) and 22 mM 
D-glucose to remove any contaminating nucleotide triphosphates. The resulting 
solution was then aliquoted and stored at -20°C (Nicholas et al., 1996). 
GF109203X (3-(N-[Dimethylamino]propyl-3-indolyl)-4-(3-indolyl)maleimide), 
H-7 (1 -(5-Isoquinolinesulfonyl)-2-methylpiperazine) and glibenclamide (A^-p-{2-(5-
chIoro-2-methoxybenzamido)ethyl} benzenesulfonyl-A^-cyclohexylurea), were from 
RBI (Natick, MA, USA). Fura-2-AM (Fura-2-acetoxymethyl ester) and Pluronic acid 
F127 were from Molecular probes (Eugene, OR, USA). 
ATP (adenosine triphosphate), CFTRinh-172 (3-[(3-trifluoromethyl)phenyl]-
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5 - [(4-carboxyphenyl)methylene] -2-thioxo-4-thiazolidinone) and chromanol 293B 
�-7V-[6-Cyano-3,4-dihydro-3-hydroxy-2，2-dimethyl-2/f-l-benzopyran-4-yl]-7V-m 
ethyl-ethanesulfonamide) were purchased from Amersham Biosciences (Piscataway, 
NJ, USA), Tocris (Ellisville, MO, USA) and Calbiochem (Darmstadt, Germany), 
respectively. 
ATP, UTP, UDP and hexokinase were dissolved in distilled water while all the 
other chemicals in dimethyl sulphoxide (DMSO). 
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2.2 Cell culture 
The human bronchial epithelial cell line, 16HBE14o-, used in the experiments 
was derived from surface epithelium of mainstream, second-generation bronchi. This 
continuous cell line was generated by transformation of normal bronchial epithelial 
cells obtained from a 1-year-old heart-lung transplant patient (Cozens et al” 1994). 
The cell line was obtained from Prof. B. J. Harvey (Royal College of Surgeons in 
Ireland, Republic of Ireland). 
16HBE140- was maintained in Minimum Essential Medium with Earle's salt 
supplemented with 10% (v/v) Fetal Bovine Serum, 1% (v/v) L-glutamine, 100 U/ml 
penicillin, and 100 jig/ml streptomycin. The cells were cultured on plastic flask coated 
with bovine collagen I purchased from BD Biosciences (Bedford, MA, USA) and 
were then incubated in humidified 95% air-5% CO2 at 37°C for seven days until the 
cells became confluent. Culture medium was changed every 3 days. Trypsinization 
was done to passage the cultured cells to new flask every 7 days. All of the cell 
culture reagents were purchased from Invitrogen (Grand Island, NY, USA). 
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2.3 Simultaneous measurement of short-circuit current (Isc) and intracellular 
calcium concentration ([Ca^ ]^)/ 
2.3.1 Preparation of 16HBE14o- cells for simultaneous measurement of Isc and 
[Ca2+], 
16HBE140- cells were seeded onto collagen-coated Transwell-COL filter 
membranes (Costar, Cambridge, MA, USA) with pores of 0.4 ^m diameter as 
previously described (Wong & Ko，2002). Each filter was affixed to a plastic circular 
disc with a culture area of 0.091 cm^ (Fig. 2.1, A). The filter was then coated with 
collagen (Fig. 2.1, B) and sterilized under ultra violet light for 45 min. After 
sterilization, the filter was placed in a six-well plate, under which was supported by a 
V-shaped glass rod so that polarized cells can access fresh culture medium from their 
basolateral side. A metal ring was placed on top of each filter to confine the 
cell-seeding area to 0.1 cm^ as illustrated in Fig. 2.2. 
The seeding density was 3 X 10^  cells/ml (3 X 10^  cells/well). The 
16HBE140- cells reached confluency after 9-10 days, with transepithelial resistance 
greater than 100 Q-cm^. 
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Figure 2.1 Preparation of the permeable support before cell seeding. A: The 
Transwell-COL filter was affixed to a plastic circular disc with a culture area of 
0.091 cm^; B: The filter was then coated with collagen. 
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Figure 2.2 16HBE14o- cells seeded onto collagen-coated Transwell-COL filters 
for simultaneous measurement of Isc and [Ca^^],. The filters were placed in a 
six-well plate. A V-shaped glass rod was placed underneath each filter whereas a 
metal ring was placed on top of the filter to confine the cell seeding area. 
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2.3.2 Measurement of Isc and transepithelial resistance with Ussing chamber 
After 9-10 days, 16HBE14o- cells grown on Transwell-COL filter reached 
confluency and were mounted in a miniature Ussing chamber as described previously 
(Wong & Ko, 2002). The Ussing chamber was equipped with 2 sets of electrodes in 
connection with a voltage-current clamp amplifier (VCC 600; Physiologic 
Instruments, San Diego, CA, USA). One set of electrodes measured the potential 
difference across the epithelium mounted in the chamber while the other set served to 
apply an external current throughout the experiments. The miniature Ussing chamber 
was connected to the electrodes by salt bridges which were made of polyethylene 
tubing containing saturated 3 M KCl in 1.5% agarose. The arrangement for the 
miniature Ussing chamber with electrodes is shown in Fig. 2.3. Before the 
experiments, the intrinsic potential difference of the settings and fluid resistance were 
offset to zero by the voltage-current clamp amplifier. 
Normal KH solution bathing the cells was kept in 37°C water bath and was 
continuously bubbled with 95% O2 and 5% CO2 to maintain the pH at 7.4 during 
experiments. Since it has been previously reported in 16HBE14o- cells that CI" is at 
equilibrium at the apical cell membrane (Cozens et al, 1994), for most experiments, 
the apical KH solution was changed to a KH solution with reduced CI" concentration 
(10 mM). This was to apply a basolateral to apical CI" gradient across the epithelia in 
order to provide a favorable gradient for CI" exit. The low [CF] solution was obtained 
by substituting NaCl, KCl, CaCb and MgCb by Na-gluconate, K-gluconate, 
Ca-gluconate and Mg-sulphate, respectively. 
During measurements, the epithelium was short-circuited using the voltage-
current clamp amplifier, by which the transepithelial potential difference was clamped 
at zero mV. The current required to reduce the potential difference between the apical 
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and basolateral bathing solutions to zero is known as short-circuit current (Isc). It is 
equivalent to the sum of active electrogenic ion fluxes across the epithelium. In our 
experiments, the upward deflection of Isc was defaulted as the indication of the net 
movement of anions from the basolateral to apical side of the epithelium. 
The transepithelial resistance of the epithelium was obtained by applying a 
constant voltage of 1 mV periodically. The resultant change in current was measured 
and the transepithelial resistance was calculated according to Ohm's law. 
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Figure 2.3 The arrangement for the miniature Ussing chamber with electrodes. 
The Ussing chamber was connected to electrodes by salt bridges. 
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2.3.3 Simultaneous measurement of Isc and [Ca^ ]^, 
16HBE14o- cells grown on Transwell-COL filters reached confluency after 
9-10 days and were ready for simultaneous measurement of Isc and [Ca^ "^ ], (Yue et aL, 
2004). The filter was short-circuited using a voltage-current clamp amplifier by which 
the transepithelial potential difference was clamped at zero mV. Meanwhile, 
intracellular calcium concentration [Ca^ ]^, was measured by microspectrofluorometric 
technique. The fluorescence system is shown in Fig. 2.4. 
Cells were loaded with Fura-2-AM by incubation for 45 min in humidified 
95% air-5% CO2 at 37°C, bathing in Normal KH solution containing 3 i^M 
Fura-2-AM and 1.6 |j,M pluronic F127. Pluronic F127 is a non-ionic surfactant polyol 
that helps to solubilize water-insoluble dyes (McFadzean & Brownlee, 1995). At the 
same time, 2.5 mM probenecid in 0.5 M NaOH (pH 7.4) was added to increase 
fluorescent dye loading and lead to a more homogeneous Fura-2 dye distribution. 
Probenecid is known to minimize the leakage of fluorescent dye by inhibiting organic 
cation extrusion systems (Leipziger et al, 1997; McAlroy et al, 2000). 
The filter bearing Fura-2-loaded epithelium was mounted in a miniature 
Ussing chamber attached to the stage of an inverted microscope (Nikon TE300, Nikon 
Co., Tokyo, Japan). The cells were viewed with a x40 extra long working distance 
objective (Nikon CFI Plan Flour ELWD, 0.6 numerical aperture). The experimental 
setup is illustrated in Fig. 2.5. To measure [Ca^^],, the cells were excited at 340 and 
380 nm UV light emitted from a Xenon arc lamp alternately at 20 Hz. Wavelength of 
520 nm was emitted and collected by a photomultiplier tube. The intensities of 
emission from 340nm and 380nm excitations and thus the Fura-2 fluorescence ratios 
(340/380 nm) were recorded by the PTI Ratio-Master fluorescence system (Photon 
Technology International, Lawrencevilie, NJ, USA) from an optical field containing 
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30 to 40 cells in the center of the epithelium. The data were shown quantitatively as a 
change in Fura-2 fluorescence ratio using FeliX software. Isc was measured with the 
voltage-current clamp amplifier simultaneously. The transepithelial potential 
difference was clamped to zero mV. 
The whole setup was stabilized with bilateral perfusion of normal KH solution 
maintained at 37°C by an in-line heater (Warner Instrument, Hamden, CT, USA) (Fig. 
2.3) for 5 min at the beginning of the experiments. The apical KH solution was then 
changed to a KH solution with reduced CI" concentration. Drugs were applied to the 
cells by a valve controller and a perfusion system. Both signals were digitized and 
recorded to computer hard disk. 
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Figure 2.4 The fluorescence system for simultaneous measurement of Isc and 
[Ca2+],. 
solution out - = " ^ ― f P _ _ = solution in 
Z j E \ 
16HBE140- cells grown 0 5 3 9 、minia ture 
on Transwell-COL filter J j 肌 Ussing chamber 
Figure 2.5 A schematic diagram of the experimental setup of miniature Ussing 
chamber on the stage of the inverted microscope. 16HBE14o- epithelium was 
mounted in the miniature Ussing chamber. The cells were viewed with a x40 extra 
long working distance objective. Bathing solutions from apical (ap) and basolateral 
(bl) sides of epithelium were perfused independently. 
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2.4 Measurement of protein kinase A activity 
The cells were seeded on Millicell Inserts membrane (Millipore Corporation, 
Billerica, MA, USA) with pores of 0.45 |im diameter. The seeding cell density was 3 
X 105 cells/ml (3 X 10^  cells/well). The confluent 16HBE14o- cells were obtained on 
day 9 or 10. The cells were incubated with non-serum medium 1 day before the 
experiment and then with normal KH solution 1 hour before the experiment. 
The 16HBE140- cells were incubated with vehicle alone, Hexokinase alone or 
UDP at either apical or basolateral sides for 5 miii. After 5-min incubation, cells were 
washed with ice-cold PBS and then lysed with 100 |il Lysis Buffer in each case. 
The PKA contents in cell samples were assayed using the PepTag® 
non-radioactive cAMP-dependent protein kinase assay system (Promega). PKA 
activity was measured as the degree of the phosphorylation of Kemptide (Leu-Arg-
Arg-Ala-Ser-Leu-Gly), a synthetic substrate specific for PKA. The phosphorylated 
and non-phosphorylated samples were separated on a 0.8% agarose gel at 100 V for 
18 min. The gel was photographed and the fluorescence intensity was quantified by 
the FluorChem™ 8000 imaging system (Alpha Innotech Corp., San Leandro, CA). 
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2.5 Data analysis 
The changes in Isc and Fura-2 fluorescence ratio (340/380 nm) in the 
experiments were quantified by measuring each parameter at the peak of each 
response and subtracting the equivalent values measured immediately prior to 
stimulation by agonists or drugs. 
For Isc response, it was normally measured by the peak current magnitude. 
Data were normalized as Isc change per unit area of epithelium (|iA/cm^). However, 
in experiments with pretreatment of blockers, some blockers might reduce the 
duration of the agonist-induced response but not the peak magnitude of the Isc 
response. As a result, it would be much informative and appropriate to compare the 
area under the Isc response curve, i.e. the total charge transfer across the epithelium, 
than to compare the peak amplitude of the Isc response (Fong et al, 1998). As an 
example, the area under Isc curve of a 300-s period can be obtained from the 
integration of the area under Isc vs time curve under the 300-s period. 
Pooled data were presented as mean 士 S.E. (i.e. standard error of the mean) of 
n experiments, where n refers to the number of experiments in each group. Statistical 
comparisons between original data before normalization were preformed by Student's 
t test, where appropriate, with p < 0.05 considered significant. Curve fitting was 
provided by a software package {GraFit 3.09b, Erithacus Software Ltd., Staines, UK). 
Results 40 
CHAPTER I I I 
RESULTS 
3.1 Apical and basolateral application of P2Y agonists induced Isc and [Ca�.], 
responses in 16HBE14o- cells 
3.1.1 Effect of apical and basolateral application of ATP on Isc and [Ca ], 
Extracellular nucleotides such ATP, UTP and UDP have been shown to 
regulate ion transport processes in epithelial cells (Ralevic & Burnstock，1998). In the 
present study, the effects of ATP, UTP and UDP on Isc and [Ca^ "^ ], were measured 
simultaneously in 16HBE14o- cells. The 340/380 nm fluorescence ratio was used to 
represent the changes in [Ca�—],. 
Fig. 3.1.1.1，A — G and Fig. 3.1.1.2, A - E show the representative recordings 
of simultaneous measurements of Isc and [Ca^^], in response to the apical application 
ofO.3 - 300 |iM ATP and basolateral application of 1 - 100 i^M ATP, respectively. 
Fig. 3.1.1.3 summarized the changes in Isc (AIsc) and cytosolic Ca^^ (AFura-2 
ratio) induced by apical or basolateral ATP applications. Apical and basolateral 
applications of ATP elicited a concentration-dependent increase in Isc, with a 
concomitant increase in [Ca^^]/. The effect on Isc was more prominent when ATP was 
added on the basolateral aspect of the epithelia (Fig. 3.1.1.3, A). In contrast, apical 
ATP apparently was more efficacious than basolateral ATP in stimulating [Ca ], 
increase (Fig. 3.1.1.3，B). The data demonstrated that both apical and basolateral ATP 
stimulated an increase in Isc and [Ca^^], in 16HBE14o- epithelia (Fig. 3.1.1.4). 
T 
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Figure 3.1.1.1 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca^^], (lower trace) in response to the apical (ap) application of 
ATP. 16HBE140- cells were initially perfused bilaterally with normal 
Krebs-Henseleit (KH) solution. The apical KH solution was then changed to a KH 
solution with reduced CI' concentration. Various concentrations of ATP (0.3 - 300 
I^ M; n = 4-6) were added to the apical side of 16HBE14o- cells (A-G). 
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Figure 3.1.1.2 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca:.], (lower trace) in response to the basolateral (bl) 
application of ATP. 16HBE14o- cells were initially perfused bilaterally with 
normal Krebs-Henseleit (KH) solution. The apical KH solution was then changed 
to a KH solution with reduced CT concentration. Various concentrations of ATP (1 
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Figure 3.1.1.3 Summary of the effects of apical (ap) and basolateral (bl) ATP on 
changes in he (A/sc) and [Ca^ ]^, (AFura-2 ratio). A: Changes in Isc in response to 
the apical and basolateral application of ATP. B: Changes in [Ca^ ]^, in response to 
the apical and basolateral application of ATP. Each data point represents the mean 
土 S.E. 
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Figure 3.1.1.4 Concentration-response relationship for the effects of apical (ap, 
upper panel) and basolateral (bl, lower panel) application of ATP upon changes in 
Isc and [Ca^ ]^, in 16HBE14o- cells. The changes (A) in Isc (left y-axis 〇）and 
Fura-2 ratio (right y-axis # ) were quantified and plotted against the concentration 
of ATP used {n = 4-6). Each data point represents the mean 土 S.E. 
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3.1.2 Effect of apical and basolateral application of UTP on Isc and [Ca^ ]^, 
Fig. 3.1.2.1, A - F and Fig. 3.1.2.2, A- E show the representative recordings of 
simultaneous measurements of Isc and [Ca^ "^ ], in response to the apical application of 
0.3 - 100 |iM UTP and basolateral application of 1 - 100 |iM UTP, respectively. 
Fig. 3.1.2.3 summarized the changes in Isc {Msc) and cytosolic Ca^ ^ (AFura-2 
ratio) induced by apical or basolateral UTP applications. Similar to ATP, apical and 
basolateral applications of UTP elicited a concentration-dependent increase in Isc, 
with a concomitant increase in [Ca^ "^ ],. The effect on Isc was more prominent when 
UTP was added on the basolateral aspect of 16HBE cells (Fig. 3.1.2.3, A). In contrast, 
apical UTP apparently was more efficacious than basolateral UTP in stimulating 
[Ca2+], increase (Fig. 3.1.2.3’ B). Again, the data demonstrated that both apical and 
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Figure 3.1.2.1 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca2+], (lower trace) in response to the apical (ap) application of 
UTP. 16HBE140- cells were initially perfused bilaterally with normal 
Krebs-Henseleit (KH) solution. The apical KH solution was then changed to a KH 
solution with reduced CI" concentration. Various concentrations of UTP (0.3 - 100 
|j.M; n 二 4-6) were added to the apical side of 16HBE14o- cells (A - F). 
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Figure 3.1.2.2 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca〗.], (lower trace) in response to the basolateral (bl) 
application of UTP. 16HBE14o- cells were initially perfused bilaterally with 
normal Krebs-Henseleit (KH) solution. The apical KH solution was then changed 
to a KH solution with reduced CI" concentration. Various concentrations of UTP (1 
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Figure 3.1.2.3 Summary of the effects of apical (ap) and basolateral (bl) UTP on 
changes in Isc (A/yc) and [Ca^ ]^, (AFura-2 ratio). A: Changes in he in response to 
the apical and basolateral application of UTP. B: Changes in [Ca^ ]^, in response to 
the apical and basolateral application of UTP. Each data point represents the mean 
土 S.E. 
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Figure 3.1.2.4 Concentration-response relationship for the effects of apical (ap, 
upper panel) and basolateral (bl, lower panel) application of UTP upon changes in 
Isc and [Ca^ "^ ], in 16HBE14o- cells. The changes (A) in Isc (left y-axis 〇）and 
Fura-2 ratio (right y-axis • ) were quantified and plotted against the concentration 
of UTP used (« = 4-6). Each data point represents the mean 土 S.E. 
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3.1.3 Effect of apical and basolateral application of UDP on Isc and [Ca^ ]^, 
Fig. 3.1.3.1, A — E and Fig. 3.1.3.2, A - E show the representative recordings 
of simultaneous measurements of Isc and [Ca^ "^ ], in response to the apical application 
of 1 - 100 |iM UDP and basolateral application of 1 - 100 |iM UDP, respectively. 
Fig. 3.1.3.3 summarized the changes in Isc (A/sc) and cytosolic Ca^ "^  (AFura-2 
ratio) induced by apical or basolateral UDP applications. Unlike ATP and UTP, apical 
UDP had a more prominent effect on Isc when applied at higher concentrations. 
Although basolateral UDP evoked an increase in Isc, the effect was variable (Fig. 
3.1.3.3, A). The increase in [Ca^^ ], upon the addition of basolateral UDP did not show 
concentration dependency as well. Basolateral application of UDP at low 
concentrations (1 -30 |iM) did not evoke any discernible increase in fluorescence 
ratio (Fig. 3.1.3.3, B). In short, the correlation between increases in Isc and [Ca^^ ], 
upon the application of basolateral UDP was not evident. However, the effect of 
apical UDP on Isc did show some degree of correlation with [Ca^^ ], (Fig. 3.1.3.4). 
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Figure 3.1.3.1 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca^ ]^, (lower trace) in response to the apical (ap) application of 
UDP. 16HBE140- cells were initially perfused bilaterally with normal 
Krebs-Henseleit (KH) solution. The apical KH solution was then changed to a KH 
solution with reduced CI" concentration. Various concentrations of UDP (1 - 100 
jj,M; n = 4-6) were added to the apical side of 16HBE14o- cells (A - E). 
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Figure 3.1.3.2 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca^ "^ ], (lower trace) in response to the basolateral (bl) 
application of UDP. 16HBE14o- cells were initially perfused bilaterally with 
normal Krebs-Henseleit (KH) solution. The apical KH solution was then changed 
to a KH solution with reduced CI" concentration. Various concentrations of UDP (1 
-100 |iM; n = 4-6) were added to the basolateral side of 16HBE14o- cells (A - E). 
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Figure 3.1.3.3 Summary of the effects of apical (ap) and basolateral (bl) UDP on 
changes in Isc (AIsc) and [Ca ], (AFura-2 ratio). A: Changes in Isc in response to 
the apical and basolateral application of UDP. B: Changes in [Ca2+], in response to 
the apical and basolateral application of UDP. Each data point represents the mean 
土 S.E. 
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Figure 3.1.3.4 Concentration-response relationship for the effects of apical (ap, 
upper panel) and basolateral (bl, lower panel) application of UDP upon changes in 
Isc and [Ca〗—], in 16HBE14o- cells. The changes (A) in Isc (left y-axis 〇）and 
Fura-2 ratio (right y-axis • ) were quantified and plotted against the concentration 
of UDP used {n = 4-6). Each data point represents the mean 士 S.E. 
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3.1.4 Summary of the effects of apical and basolateral application of ATP, UTP and 
UDP on Isc and [Ca^ ]^, 
The effects of ATP, UTP and UDP on Isc and [Ca^^ ], were compared between 
the stimulation of P2Y receptors located on apical and basolateral membranes. In 
general, P2Y agonists stimulated an increase in Isc, with a concomitant increase in 
[Ca2+],. Basolateral nucleotides had a more prominent effect on Isc. In contrast, apical 
nucleotides apparently were more efficacious than basolateral nucleotides in 
stimulating [Ca^ ]^, increase. These data indicated that both apical and basolateral 
membrane express multiple functional P2Y receptors. There was also a sidedness to 
the effects of P2Y receptors activation in stimulating an increase in Isc and [Ca^ ]^,. 
On the other hand, data showed that UDP exerted different effects on Isc and 
[Ca2+]/ in 16HBE140- cells when compared with ATP and UTP. This suggests that 
other signaling pathways or molecules might be involved in the stimulation of Isc by 
UDP. The role of P2Y6 receptor on the regulation of ion transport, at which UDP is its 
potent and selective agonists, would be of special interest. 
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3.2 Ionic mechanisms underlying the effect of apical and basolateral UDP on 
16HBE140- cells 
The presence of P2Y6 receptors has been previously reported in mouse trachea, 
human airway cells and human nasal tissues. P2Y6 receptors were found to be 
functionally active on both apical and basolateral sides of the mouse epithelium as 
well as in human airway epithelial cells (Schreiber & Kunzelmann, 2005). In the 
present study, the role of P2Y6 receptors regulating chloride secretion in 16HBE Mo-
cells was further investigated. 
In airway epithelium, transepithelial CI' secretion is dependent on two types of 
ion channels, CI" channels at the apical membrane and K+ channels at basolateral 
membrane (Welsh, 1987). Thus, various apical CI" channel blockers and basolateral 
K+ channel blockers were used to study the ionic mechanism of Isc response 
stimulated by apical and basolateral UDP in 16HBE14o- cells. 
3.2.1 Differential effect of apical and basolateral UDP on Isc 
Apical and basolateral application of 100 |iM UDP induced an increase in Isc, 
accompanied by an increase in [Ca2+], (Fig. 3.2.1.1, A and B). As shown in Fig. 
3.2.1.2, A，the stimulation'of Isc was larger when UDP was applied on the apical side 
of cells (A/sc = 17.61 士 1.66 iiA/cm�，n= \ 5) than on the basolateral side (AIsc = 6.39 
士 0.59 |aA/cm ,^ n = 12). However, apical and basolateral UDP evoked almost the 
same level of increase in [Ca2+], (Fig. 3.2.1.2, B). Therefore, the sidedness of the 
effect of UDP suggests that the apical or basolateral membrane-resident P2Y6 
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Figure 3.2.1.1 Representative recordings of simultaneous measurements of Isc 
(upper trace) and [Ca^ "^ ], (lower trace) in response to the apical (ap) and basolateral 
(bl) application of UDP. 16HBE14o- cells were initially perfused bilaterally with 
normal Krebs-Henseleit (KH) solution. The apical KH solution was then changed 
to a KH solution with reduced CI" concentration. A: 16HBE14o- cells were 
stimulated with the apical application of 100 |iM UDP {n = 15). B: Cells were 
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Figure 3.2.1.2 Summary of the effects of apical (ap) and basolateral (bl) UDP on 
changes in Isc (AIsc) and [Ca^ ]^, (AFura-2 ratio). A: Changes in Isc in response to 
the apical and basolateral application of 100 |aM UDP. B: Changes in [Ca^ ]^, in 
response to the apical and basolateral application of 100 |iM UDP. Each column 
represents the mean 士 S.E. Statistical significance is indicated by * (p < 0.05, 
Student's t test). 
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3.2.2 Effect of various apical CI" channel blockers on Isc response induced by 
apical and basolateral application of UDP 
Different apical CI" channel blockers, namely, glibenclamide, CFTRinh-172 
and DIDS, were used to study the ionic mechanism of Isc response induced by apical 
and basolateral UDP. Glibenclamide is a non-specific CFTR blocker (Rabe et al, 
1995) whereas CFTRinh-172 is a specific CFTR inhibitor (Thiagarajah et al, 2004). 
DIDS selectively blocks Ca2+-activated CI" channels (CaCC) (Anderson et al, 1992). 
The percentage of inhibition was obtained by ( I blocker / 1 control ) X 100 %, 
where I blocker was the peak magnitude of the Isc response induced when 16HBE14o-
cells were treated with the apical application of CI" channel blockers. The blockers 
were added 10 minutes prior to the apical or basolateral application of 100 jiM UDP. 
I control was the peak magnitude of the Isc response induced by the application of 100 
jaM UDP (ap or bl) without pretreatment of CI" channel blockers. 
The presence of blockers might reduce the duration of the agonist-induced 
response but not the peak magnitude of the Isc response. As a result, it would be much 
more informative and appropriate to compare the area under the Isc response curve, 
i.e. the total charge transfer across the epithelium, than to compare the peak amplitude 
of the Isc response (Fong et al, 1998). As an example, the area under Isc curve of a 
300-s period can be obtained from the integration of the area under Isc vs time curve 
under the 300-s period. Therefore, the percentage of inhibition was also obtained in 
terms of total charge transfer induced by UDP. 
Upon the apical application of UDP, glibenclamide (200 |j,M) had no 
significant effect on the reduction of Isc as well as the total charge transfer induced 
(Fig. 3.2.2.1 - 3.2.2.3). On the contrary, the more specific CFTR inhibitor, CFTRinh-
172 (10 |aM) inhibited the peak Isc response evoked by apical UDP (% inhibition = 
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46.61 士 6.63 o/o) (Fig. 3.2.2.4 and 3.2.2.5). CFTRinh-172 showed an inhibition of 
60.44 士 4.57 o/o on total charge transfer induced by apical UDP (Fig. 3.2.2.6). DIDS 
(500 p.M) nearly abolished the effect of apical UDP on Isc (Fig. 3.2.2.7 — 3.2.2.9). 
These data suggest that both apical CFTR CI" channels and Ca^ "*'-dependent CI" 
channels were involved in the chloride secretion stimulated by apical UDP. 
Upon the basolateral application of UDP, in contrast to apical UDP, 
glibenclamide (200 jiM) showed an inhibition of 31.93 士 10.14 % and 46.02 士 6.64 % 
on peak Isc and total charge transfer induced, respectively (Fig. 3.2.2.10 - 3.2.2.12). 
However, CFTRinh-172 (10 |iM) had no inhibitory effect on basolateral UDP-evoked 
Isc and total charge transfer as shown in Fig. 3.2.2.13 — 3.2.2.15. DIDS (500 p,M) 
completely abolished the effect of basolateral UDP on Isc (Fig. 3.2.2.16 - 3.2.2.18). 
These data demonstrate that at least apical Ca^ -^dependent CI" channels were 
activated due to the stimulation by basolateral UDP. 
Fig. 3.2.2.19 and 3.2.2.20 show the summary of the effects of various CI" 
channel blockers on Isc as well as total charge transfer induced by apical UDP. The 
effects of various CF channel blockers on Isc and total charge transfer induced by 
basolateral UDP were summarized in Fig. 3.2.2.21 and 3.2.2.22. 
From the data, both apical and basolateral-evoked Isc could be completely 
blocked by DIDS, suggesting the involvement of CaCC. However, the involvement of 
CFTR in mediating the apical and basolateral effect of UDP is not entirely clear. 
There is discrepancy between the effect of glibenclamide and CFTRinh-172 on apical 
and basolateral effect of UDP. Since CFTRinh-172 is a more specific inhibitor of 
CFTR, it is more likely that the effect of apical UDP is partly mediated by CFTR, 
suggesting that apical P2Y6 receptor may be also coupled to cAMP-dependent 
pathway. 
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Figure 3.2.2.1 Representative recordings of Isc in response to the apical (ap) 
application of 100 p.M UDP, with or without pretreatment of glibenclamide. 
16HBE14o- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the apical 
application of 100 i^M UDP alone {n = 6). B: Cells were treated with the apical 
application of 200 \iM glibenclamide 10 minutes prior to the apical application of 
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Figure 3.2.2.2 Effect of glibenclamide pretreatment on Isc in response to the 
apical (ap) application of 100 jiM UDP. 16HBE14o- cells were treated with the 
apical application of 200 jiM glibenclamide 10 minutes prior to the apical 
application of 100 jiM UDP (n = 6). Control was the apical application of 100 |iM 
UDP without pretreatment of glibenclamide (n = 6). Each column represents the 
mean 土 S.E. No statistical significance between control and glibenclamide-treated 
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Figure 3.2.2.3 Effect of glibenclamide pretreatment on total charge transfer 
induced by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were 
treated with the apical application of 200 pM glibenclamide 10 minutes prior to 
the apical application of 100 i^ M UDP {n = 6). Control was the apical application 
of 100 jj,M UDP without pretreatment of glibenclamide (n = 6). Each column 
represents the mean 土 S.E. No statistical significance between control and 
glibenclamide-treated group are observed (Student ,-test). 
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Figure 3.2.2.4 Representative recordings of Isc in response to the apical (ap) 
application of 100 |iM UDP, with or without pretreatment of CFTRinh-172. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the apical 
application of 100 |iM UDP alone (n = 5). B: Cells were treated with the apical 
application of 10 |iM CFTRinh-172 10 minutes prior to the apical application of 
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Figure 3.2.2.5 Effect of CFTRinh-172 pretreatment on Isc in response to the 
apical (ap) application of 100 UDP. 16HBE14o- cells were treated with the 
apical application of 10 i^M CFTRinh-172 10 minutes prior to the apical 
application of 100 ^ iM UDP (n = 5). Control was the apical application of 100 
UDP without pretreatment of CFTRinh-172 (n = 5). Each column represents the 
mean 士 S.E. Statistical significance is indicated by * (p < 0.05, Student's t test). 
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Figure 3.2.2.6 Effect of CFTRinh-172 pretreatment on total charge transfer 
induced by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were 
treated with the apical application of 10 p-M CFTRinh-172 10 minutes prior to the 
apical application of 100 jiM UDP (n = 5). Control was the apical application of 
100 [iU UDP without pretreatment of CFTRinh-172 (n = 5). Each column 
represents the mean 土 S.E. Statistical significance is indicated by * (p < 0.05, 
Student's t test). 
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Figure 3.2.2.7 Representative recordings of Isc in response to the apical (ap) 
application of 100 i^M UDP, with or without pretreatment of DIDS. 16HBEMo-
cells were initially perfused bilaterally with normal Krebs-Henseleit (KH) 
solution. The apical KH solution was then changed to a KH solution with reduced 
c r concentration. A: 16HBE14o- cells were stimulated with the apical application 
of 100 jiM UDP alone (n = 5). B: Cells were treated with the apical application of 
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Figure 3.2.2.8 Effect of DIDS pretreatment on Isc in response to the apical (ap) 
application of 100 |iM UDP. 16HBE14o- cells were treated with the apical 
application of 500 ^ iM DIDS 10 minutes prior to the apical application of 100 |iM 
UDP (n = 5). Control was the apical application of 100 |iM UDP without pre-
treatment of DIDS (« = 5). Each column represents the mean 土 S.E. Statistical 
significance is indicated by * (p < 0.05, Student's t test). 
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Figure 3.2.2.9 Effect of DIDS pretreatment on total charge transfer induced by the 
apical (ap) application of 100 |iM UDP. 16HBE14o- cells were treated with the 
apical application of 500 jiM DIDS 10 minutes prior to the apical application of 
100 i^ M UDP (n = 5). Control was the apical application of 100 [iM UDP without 
pretreatment of DIDS {n = 5). Each column represents the mean 士 S.E. Statistical 
significance is indicated by • (p < 0.05, Student's t test). 
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Figure 3.2.2.10 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 jiM UDP, with or without pretreatment of glibenclamide. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the 
basolateral application of 100 |iM UDP alone {n = 4). B: Cells were treated with 
the apical application of 200 |xM glibenclamide 10 minutes prior to the basolateral 
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Figure 3.2.2.11 Effect of glibenclamide pretreatment on Isc in response to the 
basolateral (bl) application of 100 \xM UDP. 16HBE14o- cells were treated with 
the apical application of 200 jiM glibenclamide 10 minutes prior to the basolateral 
application of 100 |iM UDP (« = 4). Control was the basolateral application of 100 
|xM UDP without pretreatment of glibenclamide (n = 4). Each column represents 
















Figure 3.2.2.12 Effect of glibenclamide pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 jiM UDP. 16HBE14o- cells were 
treated with the apical application of 200 jiM glibenclamide 10 minutes prior to 
the basolateral application of 100 |iM UDP (n = 4). Control was the basolateral 
application of 100 fiM UDP without pretreatment of glibenclamide (n = 4). Each 
column represents the mean 土 S.E. Statistical significance is indicated by * (p < 
0.05, Student's t test). 
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Figure 3.2.2.13 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 [iM UDP, with or without pretreatment of CFTRinh-172. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the 
basolateral application of 100 |iM UDP alone (n = 6). B: Cells were treated with 
the apical application of 10 |xM CFTRinh-172 10 minutes prior to the basolateral 
application of 100 [lM UDP. (n = 7). 
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Figure 3.2.2.14 Effect of CFTRinh-172 pretreatment on Isc in response to the 
basolateral (bl) application of 100 [lM UDP. 16HBE14o- cells were treated with 
the apical application of 10 jiM CFTRinh-172 10 minutes prior to the basolateral 
application of 100 |iM UDP (n = 7). Control was the basolateral application of 100 
jj.M UDP without pretreatment of CFTRinh-172 (n = 6). Each column represents 
the mean 土 S.E. No statistical significance between control and CFTRinh-
172-treated group are observed (Student /-test). 
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Figure 3.2.2.15 Effect of CFTRinh-172 pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 |j,M UDP. 16HBE14o- cells were 
treated with the apical application of 10 jiM CFTRinh-172 10 minutes prior to the 
basolateral application of 100 |j,M UDP (n = 7). Control was the basolateral 
application of 100 |iM UDP without pretreatment of CFTRinh-172 (n = 6). Each 
column represents the mean 土 S.E. No statistical significance between control 
and CFTRinh-172-treated group are observed (Student /-test). 
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Figure 3.2.2.16 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 |iM UDP, with or without pretreatment of DIDS. 16HBE14o-
cells were initially perfused bilaterally with normal Krebs-Henseleit (KH) 
solution. The apical KH solution was then changed to a KH solution with reduced 
c r concentration. A: 16HBE14o- cells were stimulated with the basolateral 
application of 100 |iM UDP alone {n = 6). B: Cells were treated with the apical 
application of 500 |aM DIDS 10 minutes prior to the basolateral application of 100 
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Figure 3.2.2.17 Effect of DIDS pretreatment on Isc in response to the basolateral 
(bl) application of 100 |iM UDP. 16HBE14o- cells were treated with the apical 
application of 500 jiM DIDS 10 minutes prior to the basolateral application of 100 
|j.M UDP {n = 9). Control was the basolateral application of 100 |iM UDP without 
pretreatment of DIDS {n = 6). Each column represents the mean 土 S.E. Statistical 
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Figure 3.2.2.18 Effect of DIDS pretreatment on total charge transfer induced by 
the basolateral (bl) application of 100 \iM UDP. 16HBE14o- cells were treated 
with the apical application of 500 {iM DIDS 10 minutes prior to the basolateral 
application of 100 |j,M UDP (n = 9). Control was the basolateral application of 100 
P-M UDP without pretreatment of DIDS (n = 6). Each column represents the mean 
土 S.E. Statistical significance is indicated by * < 0.05, Student's t test). 
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Figure 3.2.2.19 Summary of the effects of various CI" channel blockers including 
glibenclamide, CFTRinh-172 and DIDS pretreatment on Isc in response to the 
apical (ap) application of 100 pM UDP. 16HBE14o- cells were treated with 
glibenclamide (apical; 200 |jM; n = 6), CFTRinh-172 (apical; 10 |iM; n = 5) and 
DIDS (apical; 500 |iM; n = 5), respectively, 10 minutes prior to the apical 
application of 100 ^M UDP. Control was the apical application of 100 |iM UDP 
alone {n = 5-6). Each column represents the mean 士 S.E. Statistical significance is 
indicated by * (/? < 0.05, Student's t test). 
Results 80 
1 2 0 「 
a - 100 -
2 ^ 
8 0 -
h A • * 
I i 4 。 -
• • * 
0 L 丁 
P « K 8 
I E S • 5 iS = c3 o £ 
i S o 
Figure 3.2.2.20 Summary of the effects of various CI" channel blockers including 
glibenclamide, CFTRinh-172 and DIDS pretreatment on total charge transfer 
induced by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were 
treated with glibenclamide (apical; 200 |aM; n = 6)，CFTRinh-172 (apical; 10 j^ M; 
n = 5) and DIDS (apical; 500 jiM; n = 5), respectively, 10 minutes prior to the 
apical application of 100 |xM UDP. Control was the apical application of 100 jiM 
UDP alone {n = 5-6). Each column represents the mean 士 S.E. Statistical 
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Figure 3.2.2.21 Summary of the effects of various CI" channel blockers including 
glibenclamide, CFTRinh-172 and DIDS pretreatment on Isc in response to the 
basolateral (bl) application of 100 jiM UDP. 16HBE14o- cells were treated with 
glibenclamide (apical; 200 |iM; n = 4)，CFTRinh-172 (apical; 10 |iM; n = l) and 
DIDS (apical; 500 |j.M; n = 9)，respectively, 10 minutes prior to the basolateral 
application of 100 |iM UDP. Control was the basolateral application of 100 |iM 
UDP alone (« = 4-6). Each column represents the mean 士 S.E. Statistical 
significance is indicated by * (p < 0.05，Student's t test). 
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Figure 3.2.2.22 Summary of the effects of various CI" channel blockers including 
glibenclamide, CFTRinh-172 and DIDS pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 |iM UDP. 16HBE14o- cells were 
treated with glibenclamide (apical; 200 jiM; n = 4), CFTRinh-172 (apical; 10 [iM; 
n = 7) and DIDS (apical; 500 |iM; n = 9), respectively, 10 minutes prior to the 
basolateral application of 100 |iM UDP. Control was the basolateral application of 
100 jiM UDP alone {n = 4-6). Each column represents the mean 士 S.E. Statistical 
significance is indicated by * (p < 0.05, Student's t test). 
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3.2.3 Effect of various basolateral K+ channel blockers on Isc response induced by 
apical and basolateral application of UDP 
Different basolateral K+ channel blockers, namely, chromanol 293B, 
clotrimazole and TRAM-34, were used to study the ionic mechanism of Isc response 
induced by apical and basolateral UDP. Chromanol 293B is a cAMP-dependent K+ 
channel blocker (Mall et al, 2000). Both clotrimazole (Ishii et al, 1997) and 
TRAM-34 block intermediate-conductance Ca^ -^activated K+ channels, at which 
TRAM-34 is of higher selectivity (Wulff eU/., 2001). 
Similar to the previous experiments as described in section 3.2.2, the 
percentage of inhibition was obtained by ( / blocker 丨 / control) X 100 %, where J blocker 
was the peak magnitude of the Isc response induced when 16HBE14o- cells were 
treated with the basolateral application of K+ channel blockers. The blockers were 
added 10 minutes prior to the apical or basolateral application of 100 |a,M UDP. I control 
was the peak magnitude of the Isc response induced by the application of 100 [iM 
UDP (ap or bl) without pretreatment of K+ channel blockers. As mentioned previously, 
the area under the Isc response curve, i.e. the total charge transfer across the 
epithelium, was also used to compare the effect of various K+ channel blockers. 
Upon the apical application of UDP, chromanol 293B (10 |iM) had no 
significant effect on the reduction of Isc as well as the total charge transfer induced 
(Fig. 3.2.3.1 - 3.2.3.3). On the other hand, as shown in Fig. 3.2.3.4 and 3.2.3.5， 
clotrimazole (100 i^M) inhibited the peak Isc response evoked by apical UDP (% 
inhibition = 38.31 土 6.22 %). Clotrimazole also showed an inhibition of 46.57 士 7.2 % 
on total charge transfer induced by apical UDP (Fig. 3.2.3.6). For TRAM-34 (10 |iM), 
it appeared to have no significant effect on peak magnitude of Isc evoked by apical 
UDP (Fig. 3.2.3.7 and 3.2.3.8). However, when measured in terms of total charge 
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transfer induced, TRAM-34 showed an inhibition of 22.83 土 1.07 % on total charge 
transfer evoked by apical UDP (Fig. 3.2.3.9). These results demonstrate that 
basolateral Ca '^^ -activated K+ channels but not cAMP-dependent K+ channels were 
stimulated by apical application of UDP. 
The effect of various K+ channel blockers on basolateral application of UDP 
was examined as well. Upon the basolateral application of UDP, chromanol 293B (10 
I^ M) had no significant effect on the reduction of Isc as well as the total charge 
transfer induced (Fig. 3.2.3.10 一 3.2.3.12). In contrast, clotrimazole (100 jiM) 
significantly reduced the Isc evoked by basolateral UDP, with the % inhibition of 
70.18 士 5.33 o/o (Fig. 3.2.3.13 and 3.2.3.14). The presence of clotrimazole showed an 
inhibition of 79.47 士 0.49 % on total charge transfer induced by basolateral UDP (Fig. 
3.2.3.15). TRAM-34 (10 also showed an inhibition of 27.14 士 2.39 % and 35.01 
士 6.41 o/o on Isc and total charge transfer induced by basolateral UDP, respectively 
(Fig. 3.2.3.16 — 3.2.3.18). These data show that basolateral Ca^ -^dependent K+ 
channels but not cAMP-dependent K+ channels were activated due to the stimulation 
by basolateral UDP. 
Fig. 3.2.3.19 and 3.2.3.20 show a summary of the effects of various K+ 
channel blockers on Isc as well as total charge transfer induced by apical UDP. The 
effects of various K+ channel blockers on Isc and total charge transfer induced by 
basolateral UDP were summarized in Fig. 3.2.3.21 and 3.2.3.22. 
Both apical and basolateral UDP-evoked Isc could be blocked by clotrimazole 
and TRAM-34, suggesting the involvement of clotrimazole- and TRAM-34-sensitive 
K+ channels. On the contrary, chromanol 293B showed no inhibitory effect on both 
apical and basolateral UDP-evoked Isc. Together with the data from previous section, 
these results suggest that apical P2Y6 receptor might be coupled to both Ca^ -^ and 
cAMP-dependent pathways while basolateral P2Y6 receptors might be coupled to 
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Ca2+-dependent pathway but not cAMP-dependent pathway. 
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Figure 3.2.3.1 Representative recordings of Isc in response to the apical (ap) 
application of 100 |iM UDP, with or without pretreatment of chromanol 293B. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the apical 
application of 100 |iM UDP alone {n = 7). B: Cells were treated with the 
basolateral application of 10 |iM chromanol 293B 10 minutes prior to the apical 
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Figure 3.2.3.2 Effect of chromanol 293B pretreatment on Isc in response to the 
apical (ap) application of 100 jiM UDP. 16HBE14o- cells were treated with the 
basolateral application of 10 chromanol 293B 10 minutes prior to the apical 
application of 100 |aM UDP {n = 9). Control was the apical application of 100 \iM 
UDP without pretreatment of chromanol 293B (n = 7). Each column represents the 
mean 土 S.E. No statistical significance between control and chromanol 293B-
treated group are observed (Student /-test). 
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Figure 3.2.3.3 Effect of chromanol 293B pretreatment on total charge transfer 
induced by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were 
treated with the basolateral application of 10 |iM chromanol 293B 10 minutes 
prior to the apical application of 100 jiM UDP (n = 9). Control was the apical 
application of 100 j^ M UDP without pretreatment of chromanol 293B (n = 7). Each 
column represents the mean 土 S.E. No statistical significance between control 
and chromanol 293B-treated group are observed (Student 〜test). 
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Figure 3.2.3.4 Representative recordings of Isc in response to the apical (ap) 
application of 100 p-M UDP, with or without pretreatment of clotrimazole. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the apical 
application of 100 [lM UDP alone (n = 7). B: Cells were treated with the 
basolateral application of 100 jiM clotrimazole 10 minutes prior to the apical 
application of 100 UDP. (n = 9). 
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Figure 3.2.3.5 Effect of clotrimazole pretreatment on Isc in response to the apical 
(ap) application of 100 jiM UDP. 16HBE14o- cells were treated with the 
basolateral application of 100 jiM clotrimazole 10 minutes prior to the apical 
application of 100 |iM UDP {n = 9). Control was the apical application of 100 [iM 
UDP without pretreatment of clotrimazole (n = 7). Each column represents the 
mean 士 S.E. Statistical significance is indicated by * (p< 0.05, Student's t test). 
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Figure 3.2.3.6 Effect of clotrimazole pretreatment on total charge transfer induced 
by the apical (ap) application of 100 UDP. 16HBE14o- cells were treated with 
the basolateral application of 100 |aM clotrimazole 10 minutes prior to the apical 
application of 100 jiM UDP (n = 9). Control was the apical application of 100 [iM 
UDP without pretreatment of clotrimazole (n = 7). Each column represents the 
mean 土 S.E. Statistical significance is indicated by * (p < 0.05, Student's t test). 
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Figure 3.2.3.7 Representative recordings of Isc in response to the apical (ap) 
application of 100 |iM UDP, with or without pretreatment of TRAM-34. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the apical 
application of 100 jiM UDP alone (« = 6). B: Cells were treated with the 
basolateral application of 10 |iM TRAM-34 10 minutes prior to the apical 
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Figure 3.2.3.8 Effect of TRAM-34 pretreatment on Isc in response to the apical 
(ap) application of 100 [iM UDP. 16HBE14o- cells were treated with the 
basolateral application of 10 jiM TRAM-34 10 minutes prior to the apical 
application of 100 \xM UDP (n = 8). Control was the apical application of 100 jiM 
UDP without pretreatment of TRAM-34 (n = 6). Each column represents the mean 
士 S.E. No statistical significance between control and TRAM-34-treated group are 
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Figure 3.2.3.9 Effect of TRAM-34 pretreatment on total charge transfer induced 
by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were treated with 
• the basolateral application of 10 |iM TRAM-34 10 minutes prior to the apical 
application of 100 |aM UDP (n = 8). Control was the apical application of 100 |iM 
UDP without pretreatment of TRAM-34 (n = 6). Each column represents the mean 
士 S.E. Statistical significance is indicated by * (/? < 0.05, Student's t test). 
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Figure 3.2.3.10 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 |iM UDP, with or without pretreatment of chromanol 293B. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the 
basolateral application of 100 jiM UDP alone {n = 6). B: Cells were treated with 
the basolateral application of 10 jiM chromanol 293B 10 minutes prior to the 










Figure 3.2.3.11 Effect of chromanol 293B pretreatment on Isc in response to the 
basolateral (bl) application of 100 [iM UDP. 16HBE14o- cells were treated with 
the basolateral application of 10 chromanol 293B 10 minutes prior to the 
basolateral application of 100 |j,M UDP (n = 6). Control was the basolateral 
application of 100 jiM UDP without pretreatment of chromanol 293B (n = 6). Each 
column represents the mean 土 S.E. No statistical significance between control 












Figure 3.2.3.12 Effect of chromanol 293B pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 |iM UDP. 16HBE14o- cells were 
treated with the basolateral application of 10 jiM chromanol 293B 10 minutes 
prior to the basolateral application of 100 |iM UDP (n = 6). Control was the 
basolateral application of 100 |iM UDP without pretreatment of chromanol 293B 
(n = 6). Each column represents the mean 土 S.E. No statistical significance 
between control and chromanol 293B-treated group are observed (Student r-test). 
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Figure 3.2.3.13 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 |j,M UDP, with or without pretreatment of clotrimazole. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CP concentration. A: 16HBE14o- cells were stimulated with the 
basolateral application of 100 jiM UDP alone {n = 6). B: Cells were treated with 
the basolateral application of 100 [iM clotrimazole 10 minutes prior to the 
basolateral application of 100 pM UDP. (n = 8). 
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Figure 3.2.3.14 Effect of clotrimazole pretreatment on Isc in response to the 
basolateral (bl) application of 100 |iM UDP. 16HBE14o- cells were treated with 
the basolateral application of 100 jiM clotrimazole 10 minutes prior to the 
basolateral application of 100 jiM UDP (n = 8). Control was the basolateral 
application of 100 |j.M UDP without pretreatment of clotrimazole (« = 6). Each 
column represents the mean 土 S.E. Statistical significance is indicated by * (p < 
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Figure 3.2.3.15 Effect of clotrimazole pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 \M UDP. 16HBE14o- cells were 
treated with the basolateral application of 100 [iM clotrimazole 10 minutes prior to 
the basolateral application of 100 |iM UDP (n = 8). Control was the basolateral 
application of 100 |iM UDP without pretreatment of clotrimazole (n = 6). Each 
column represents the mean 土 S.E. Statistical significance is indicated by * (p < 
0.05, Student's t test). 
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Figure 3.2.3.16 Representative recordings of Isc in response to the basolateral (bl) 
application of 100 \iM UDP, with or without pretreatment of TRAM-34. 
16HBE140- cells were initially perfused bilaterally with normal Krebs-Henseleit 
(KH) solution. The apical KH solution was then changed to a KH solution with 
reduced CI" concentration. A: 16HBE14o- cells were stimulated with the 
basolateral application of 100 i^M UDP alone (n = 6). B: Cells were treated with 
the basolateral application of 10 |j.M TRAM-34 10 minutes prior to the basolateral 
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Figure 3.2.3.17 Effect of TRAM-34 pretreatment on Isc in response to the 
basolateral (bl) application of 100 |iM UDP. 16HBE14o- cells were treated with 
the basolateral application of 10 |j.M TRAM-34 10 minutes prior to the basolateral 
application of 100 |iM UDP {n = 6). Control was the basolateral application of 100 
I^ M UDP without pretreatment of TRAM-34 {n = 6). Each column represents the 
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Figure 3.2.3.18 Effect of TRAM-34 pretreatment on total charge transfer induced 
by the basolateral (bl) application of 100 UDP. 16HBE14o- cells were treated 
with the basolateral application of 10 |iM TRAM-34 10 minutes prior to the 
basolateral application of 100 ^M UDP (n = 6). Control was the basolateral 
application of 100 \iM UDP without pretreatment of TRAM-34 (n = 6). Each 
column represents the mean 土 S.E. Statistical significance is indicated by * (p < 
0.05，Student's t test). 
Results 104 
1 2 0 「 
<D - 1 0 0 -
s I 
B. o ~ I 
g o 80 - 工 ^ ^ 
* 
i?： Ill 




Figure 3.2.3.19 Summary of the effects of various K+ channel blockers including 
chromanol 293B，clotrimazole and TRAM-34 pretreatment on Isc in response to 
the apical (ap) application of 100 jiM UDP. 16HBE14o- cells were treated with 
chromanol 293B (basolateral; 10 |iM; n = 9), clotrimazole (basolateral; 100 |iM; n 
=9) and TRAM-34 (basolateral; 10 |xM; n = 8), respectively, 10 minutes prior to 
the apical application of 100 |iM UDP. Control was the apical application of 100 
|iM UDP alone {n = 6-7). Each column represents the mean 士 S.E. Statistical 
significance is indicated by * < 0.05, Student's t test). 
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Figure 3.2.3.20 Summary of the effects of various K+ channel blockers including 
chromanol 293B, clotrimazole and TRAM-34 pretreatment on total charge transfer 
induced by the apical (ap) application of 100 jiM UDP. 16HBE14o- cells were 
treated with chromanol 293B (basolateral; 10 |iM; n = 9), clotrimazole 
(basolateral; 100 jiM; « = 9) and TRAM-34 (basolateral; 10 |iM; n = 8), 
respectively, 10 minutes prior to the apical application of 100 pM UDP. Control 
was the apical application of 100 |iM UDP alone (n = 6-7). Each column 
represents the mean 土 S.E. Statistical significance is indicated by * < 0.05, 
Student's t test). 
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Figure 3.2.3.21 Summary of the effects of various K+ channel blockers including 
chromanol 293B, clotrimazole and TRAM-34 pretreatment on Isc in response to 
the basolateral (bl) application of 100 jiM UDP. 16HBE14o- cells were treated 
with chromanol 293B (basolateral; 10 |iM; n = 6), clotrimazole (basolateral; 100 
|iM; n = S) and TRAM-34 (basolateral; 10 |iM; n = 6), respectively, 10 minutes 
prior to the basolateral application of 100 |iM UDP. Control was the basolateral 
application of 100 |iM UDP alone {n = 6). Each column represents the mean 士 S.E. 
Statistical significance is indicated by * (p < 0.05, Student's t test). 
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Figure 3.2.3.22 Summary of the effects of various K+ channel blockers including 
chromanol 293B, clotrimazole and TRAM-34 pretreatment on total charge transfer 
induced by the basolateral (bl) application of 100 ^ iM UDP. 16HBE14o- cells were 
treated with chromanol 293B (basolateral; 10 |iM; n = 6), clotrimazole 
(basolateral; 100 « = 8) and TRAM-34 (basolateral; 10 i^M; n = 6), 
respectively, 10 minutes prior to the basolateral application of 100 jiM UDP. 
Control was the basolateral application of 100 |iM UDP alone {n = 6). Each 
column represents the mean 士 S.E. Statistical significance is indicated by * (p < 
0.05, Student's t test). 
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3.3 Involvement of other signaling molecules or pathways in regulation of the 
chloride secreting response evoked by apical and basolateral UDP 
P2Y6 receptors have been shown to couple to two independent intracellular 
second messenger pathways, thereby increasing both intracellular Ca^ "^  and cAMP 
(Kottgen et al, 2003). Our previous data also suggested that UDP induced-Cl" 
secretion may be mediated through both Ca^ -^dependent CI" channels (CaCC) and 
cAMP-dependent CI" channels (CFTR). Thus, in addition to the Ca^ -^dependent 
pathway, the cAMP-dependent pathway underlying the effect of UDP was studied, by 
which PKA assay was employed. 
On the other hand, PKC was shown to regulate human airway secretion via 
interactions with CFTR. Recent studies reported that Ca^^ -independent PKC regulates 
cAMP-dependent stimulation of the CFTR CI" channel in Calu-3 cells, which is an 
airway epithelial cell line (Liedtke & Cole, 1998). In our study, PKC inhibitors has 
been used to investigate the involvement of PKC on Isc in response to apical and 
basolateral application of UDP. 
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3.3.1 Effect of apical and basolateral UDP on PKA activity 
‘ PKA activity was measured in 16HBE14o- cells using a commercial based 
assay (Promega) that measures the phosphorylation of Kemptide (Leu-Arg-Arg-Ala-
Ser-Leu-Gly), a synthetic substrate specific for PKA. As shown in Fig. 3.3.1.1, A, 
phosphorylated peptide migrated toward the positively charged anode. PKA activity 
was the measurement of the function of fluorescence intensity. Apical and basolateral 
application of 100 |iM UDP for 5 min significantly increased the PKA activity by 
about 71 o/o and 61 % (« = 6), respectively, when compared with cells treated with 
vehicle control alone (Fig. 3.3.1.1, B). Because the UDP solution also contained 
hexokinase (HK), the effect of hexokinase on PKA activity was examined. The result 
indicated that hexokinase added to the apical or basolateral aspect of the epithelia did 
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Figure 3.3.1.1 Effect of apical (ap) and basolateral (bl) UDP on PKA activity. A: 
confluent 16HBE14o- cells grown on Transwell-COL filter were stimulated with 
either vehicle alone (Control) or 100 jxM UDP added to the apical (ap) or 
basolateral (bl) aspects of epithelia for 5 min. The positive and negative controls 
provided by the assay kit are shown in lanes 1 and 2. PKA activity was measured 
as a function of fluorescence intensity. This photo is the representative of six 
experiments. B: summarized data showing the relative fluorescence level as 
compared with control level. Each column represents the mean 士 S.E. Statistical 
significance is indicated by * (p < 0.05, Student's t test). 
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3.3.2 Effect of PKC inhibitors on Isc response induced by apical and basolateral 
application of UDP 
Two PKC inhibitors, H-7 and GF109203x, were used to examine whether 
PKC pathway is involved in mediating chloride secretion stimulated by apical and 
basolateral UDP. H-7 is a nonspecific PKC inhibitor (Nixon et al, 1991) while 
GF109203X is a specific PKC inhibitor (Toullec et al, 1991). 
Upon the apical application of UDP, H-7 (10 j^ M) inhibited Isc response 
evoked by apical UDP (% inhibition = 21.48 ± 8.26 %) as shown in Fig. 3.3.2.1. It 
showed an inhibition of 36.75 士 3.52 % on total charge transfer induced by apical 
UDP (Fig. 3.3.2.2). Conversely, GF109203x (5 _ appeared to augment the peak 
magnitude of Isc evoked by apical UDP (Fig. 3.3.2.3). However, when measured in 
terms of total charge transfer induced, GF109203x showed no significant effect on 
total charge transfer evoked by apical UDP (Fig. 3.3.2.4). 
Upon the basolateral application of UDP, both H-7 (10 |iM) and GF109203x 
(5 p-M) had no significant effect on Isc as well as the total charge transfer induced as 
shown in Fig. 3.3.2.5 and 3.3.2.6 as well as Fig. 3.3.2.7 and 3.3.2.8, respectively. 
Fig. 3.3.2.9 and 3.3.2.10 show a summary of the effects of PKC inhibitors on 
Isc as well as total charge transfer induced by apical UDP. The effects of PKC 
inhibitors on Isc and total charge transfer induced by basolateral UDP were 
summarized in Fig. 3.3.2.11 and 3.3.2.12. 
Taken together, these results suggest that PKC is not involved in mediating the 
basolateral effect of UDP on Isc. Although the apical UDP-induced Isc was inhibited 
by H-7, GF109203X, a potent and selective inhibitor of PKC, did not show any 
inhibitory effect on the peak Isc or the total charge transfer. Moreover, H-7 has been 
reported to potentially block PKA activity in vitro (Hardie, 1993). Therefore, PKC 
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activation may not bie involved in mediating the apical UDP effect as well. 
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Figure 3.3.2.1 Effect of H-7 pretreatment on Isc in response to the apical (ap) 
application of 100 jiM UDP. 16HBE14o- cells were treated with the apical 
application of 10 |a.M H-7 10 minutes prior to the apical application of 100 j^ M 
UDP {n = 4). Control was the apical application of 100 ^M UDP without 
pretreatment of H-7 {n = 4). Each column represents the mean 土 S.E. Statistical 
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Figure 3.3.2.2 Effect of H-7 pretreatment on total charge transfer induced by the 
apical (ap) application of 100 i^M UDP. 16HBE14o- cells were treated with the 
apical application of 10 ^ iM H-7 10 minutes prior to the apical application of 100 
jO-M UDP (n = 4). Control was the apical application of 100 [iM UDP without 
pretreatment of H-7 (« = 4). Each column represents the mean 士 S.E. Statistical 
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Figure 3.3.2.3 Effect of GF109203x pretreatment on Isc in response to the apical 
(ap) application of 100 jiM UDP. 16HBE14o- cells were treated with the apical 
application of 5 i^ M GF109203x 10 minutes prior to the apical application of 100 
I^ M UDP (« = 4). Control was the apical application of 100 |iM UDP without 
pretreatment of GF109203x {n = 4). Each column represents the mean 士 S.E. 
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Figure 3.3.2.4 Effect of GF109203x pretreatment on total charge transfer induced 
by the apical (ap) application of 100 |iM UDP. 16HBE14o- cells were treated with 
the apical application of 5 |jM GF109203x 10 minutes prior to the apical 
application of 100 |iM UDP (n = 4). Control was the apical application of 100 |iM 
UDP without pretreatment of GF109203x {n = 4). No statistical significance 
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Figure 3.3.2.5 Effect of H-7 pretreatment on Isc in response to the basolateral (bl) 
application of 100 |iM UDP. 16HBE14o- cells were treated with the apical 
application of 10 jiM H-7 10 minutes prior to the basolateral application of 100 
fxM UDP {n = 4). Control was the basolateral application of 100 \iM UDP without 
pretreatment of H-7 {n = 4). Each column represents the mean 土 S.E. No 
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Figure 3.3.2.6 Effect of H-7 pretreatment on total charge transfer induced by the 
basolateral (bl) application of 100 jiM UDP. 16HBE14o- cells were treated with 
the apical application of 10 jiM H-7 10 minutes prior to the basolateral application 
of 100 |iM UDP {n = 4). Control was the basolateral application of 100 |iM UDP 
without pretreatment of H-7 {n = 4). Each column represents the mean 土 S.E. No 
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Figure 3.3.2.7 Effect of GF109203x pretreatment on Isc in response to the 
basolateral (bl) application of 100 UDP. 16HBE14o- cells were treated with 
the apical application of 5 |j,M GF109203x 10 minutes prior to the basolateral 
application of 100 |j.M UDP (n = 4). Control was the basolateral application of 100 
(xM UDP without pretreatment of GF109203x (n = 4). Each column represents the 
mean 土 S.E. No statistical significance between control and GF109203x-treated 
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Figure 3.3.2.8 Effect of GF109203x pretreatment on total charge transfer induced 
by the basolateral (bl) application of 100 pM UDP. 16HBE14o- cells were treated 
with the apical application of 5 GF109203x 10 minutes prior to the basolateral 
application of 100 jiM UDP (n = 4). Control was the basolateral application of 100 
|j,M UDP without pretreatment of GF109203x (n = 4). Each column represents the 
mean 土 S.E. No statistical significance between control and GF 109203x-treated 
group are observed (Student /-test). 
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Figure 3.3.2.9 Summary of the effects of PKC inhibitors including H-7 and 
GF109203x pretreatment on Isc in response to the apical (ap) application of 100 
^M UDP. 16HBE140- cells were treated with H-7 (apical; 10 [iM; n = 4) and 
GF109203X (apical; 5 |aM; n = 4), respectively, 10 minutes prior to the apical 
application of 100 |iM UDP. Control was the apical application of 100 )iM UDP 
alone (n = 4). Each column represents the mean 士 S.E. Statistical significance is 
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Figure 3.3.2.10 Summary of the effects of PKC inhibitors including H-7 and 
GF109203x pretreatment on total charge transfer induced by the apical (ap) 
application of 100 jiM UDP. 16HBE14o- cells were treated with H-7 (apical; 10 
^iM; n = 4) and GF109203x (apical; 5 |j.M; n = 4), respectively, 10 minutes prior to 
the apical application of 100 |iM UDP. Control was the apical application of 100 
jiM UDP alone {n = 4). Each column represents the mean 士 S.E. Statistical 
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Figure 3.3.2.11 Summary of the effects of PKC inhibitors including H-7 and 
GF109203x pretreatment on Isc in response to the basolateral (bl) application of 
100 [iM UDP. 16HBE140- cells were treated with H-7 (apical; 10^iM;« = 4) and 
GF109203x (apical; 5 |iM; n = 4)，respectively, 10 minutes prior to the basolateral 
application of 100 |iM UDP. Control was the basolateral application of 100 pM 
UDP alone {n = 4). Each column represents the mean 士 S.E. No statistical 
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Figure 3.3.2.12 Summary of the effects of PKC inhibitors including H-7 and 
GF109203x pretreatment on total charge transfer induced by the basolateral (bl) 
application of 100 jiM UDP. 16HBE14o- cells were treated with H-7 (apical; 10 
I^M; n = 4) and GF109203x (apical; 5 jxM; n = 4), respectively, 10 minutes prior to 
the basolateral application of 100 jiM UDP. Control was the basolateral application 
of 100 |iM UDP alone {n = 4). Each column represents the mean 士 S.E. No 
statistical significance between control and PKC inhibitors-treated group are 




4.1 Simultaneous measurement of Isc and [Ca^ ]^/ upon apical and basolateral 
application of P2Y agonists in 16HBE14o- cells 
Human airways are lined with a film of airway surface liquid (ASL). ASL is 
essential for healthy airway function, by which the efficiency of airway mucus 
clearance will be greatly affected by its thickness and composition. This is in turn 
influenced by the ion and water absorptive and secretory functions of the airway 
epithelium that hydrate ASL and affect mucus clearance. Previous studies in human 
airways have addressed a main role for P2Y receptors but a minor role for P2X 
receptors in the regulation of ion transport in airway epithelial cells, where P2Y 
receptors are predominantly expressed in apical and/or basolateral membranes 
(Paradiso et al, 1995; Leipziger, 2003). In the present study, the effect of different 
P2Y agonists such as extracellular ATP, UTP and UDP on basal short-circuit current 
{Isc) and intracellular calcium ([Ca^ ]^,) in 16HBE14o- cells was examined. With 
simultaneous measurement techniques, the concurrent effects of P2Y agonists on Isc 
and [Ca2+], could be examined in detail. This enables better quantization of the role of 
intracellular Ca^ ^ in modulating anion transport activity in polarized cells (Wong & 
Ko, 2002). The epithelia were stimulated with either apical or basolateral application 
of ATP, UTP and UDP. In addition, various concentrations of P2Y agonists were 
employed to study the concentration-response relationship for the effects of agonists 
upon changes in Isc and [Ca〗.],. 
The effects of ATP, UTP and UDP on Isc and [Ca^ ]^,- were compared between 
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the stimulation of P2Y receptors located on apical and basolateral membranes. 
Measurement of Isc showed the transepithelial resistance of the cells was 113.4 士 1.6 
n-cm^ {n = 35). In general, ATP, DTP as well as UDP stimulated an increase in Isc, 
with a concomitant increase in [Ca^^ ],. The increase in Isc could be due to either 
cation or anion secretion across the epithelia. In the experiments, the epithelia were 
bathed in asymmetric KH solution in order to apply a basolateral to apical CI" gradient. 
Under such conditions, the increase in Isc would be due to CI" secretion (Cozens et al, 
1994; Bernard et al, 2005). This is in consistence with earlier study that no sodium 
transport could be detected in 16HBE14o- cells (Bernard et al, 2003). The results 
demonstrated that both apical and basolateral sides of 16HBE14o- cells contain P2Y 
receptors coupled to intracellular Ca^ ^ release, by which a Ca^ "^ -dependent CI" 
secretion is stimulated. Additionally, the CI" secretion has been stimulated by P2Y 
agonists with an increase in [Ca^ ]^, in concentration-dependent manner (Fig. 3.1.1.4 
and 3.1.2.4). Besides, these data indicated that both apical and basolateral membrane 
express multiple functional P2Y receptors. ATP, UTP and UDP have been reported to 
be the preferential agonists of P2Y2, P2Y4 and P2Y6 receptors, respectively (King et 
al., 2001; Communi et al., 2001)，suggesting the expression of P2Y2, P2Y4 and P2Y6 
receptors on apical and basolateral membranes in 16HBE14o- cells. The data are 
consistent with our earlier molecular study using quantitative real-time PCR, which 
suggests the expression of mRNA coding for P2Yi, P2Y2, P2Y4 and P2Y6 receptor 
subtypes (Wong et al, 2006). 
Furthermore, a sidedness to the effects of apical and basolateral P2Y receptors 
activation in stimulating an increase in Isc and [Ca^^ ], was observed. Basolateral ATP 
had a more prominent effect on Isc. In contrast, apical ATP apparently were more 
efficacious than basolateral ATP in stimulating [Ca^ "^ ], increase (Fig. 3.1.1.3). UTP 
also elicited similar asymmetric patterns (Fig. 3.1.2.3). This may be attributed to the 
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asymmetric expression of functional P2Y receptors in polarized 16HBE14o- cells and 
that the receptors apparently couple more efficaciously to Ca^ ^ signaling on one side 
than on the other side, as suggested by Lazarowski et al (1997). This may enable the 
cells to respond selectively to extracellular nucleotides stimulation at the apical or 
basolateral barriers in response to local stresses in the airways and thus exert 
coordinated autocrine/paracrine effects on ion transport (Homolya et al, 2000). 
Moreover, the presence of basolateral Ca^^ -activated K+ channels in many epithelial 
cells have been shown to play an important role in driving apical CI" exit via different 
types of c r channels (MacVinish et al, 1998). Thus, it is possible that upon the 
activation of basolateral P2Y receptors, the localized [Ca^^ ], increased near basolateral 
membrane domain could readily activate more K+ channels, which in turn generate a 
larger membrane potential effect in driving apical CI" secretion. This may explain the 
more prominent effect of basolateral nucleotides on Isc despite their weaker effect on 
[Ca2+]/ when compared with that of apical nucleotides. In contrast, UDP exerted 
different effects on Isc and [Ca2+], in 16HBE14o- cells when compared with ATP and 
UTP. The effect of apical UDP on Isc showed only some degree of correlation with 
[Ca2+],. On the other hand, the effect of basolateral UDP on Isc was variable and 
failed to evoke any discernible increase in [Ca2+], at concentrations below 100 |iM 
(Fig. 3.1.3.3 and 3.1.3.4). The regulatory pathway(s) underlying the asymmetric 
effects of nucleotides on Isc and [Ca^ ]^, remains to be elucidated. Yet, the differential 
effect of apical and basolateral UDP on Isc draws our attention to further investigate 
the function of P2Y6 receptors in 16HBE14o- cells. 
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4.2 Ionic mechanism underlying the effect of apical and basolateral UDP on 
16HBE140- cells 
The prominent effects of extracellular nucleotides in stimulating CI" secretion 
were well demonstrated. Stimulation of P2Y receptors increases intracellular calcium 
concentration, and subsequently activates Ca^ -^dependent CI" secretion and inhibits 
Na+ reabsorption, resulting in an increased CI" secretion (Knowles et al, 1991; Inglis 
et al, 1999; Kunzelmann et al, 2005). In the airways, P2Y2 receptor is by far the best 
characterized P2Y receptors, which couples to PLC and Ca^ "^  signaling cascade and 
thus allows ATP and UTP to increase [Ca^ ]^, (Nicholas et al, 1996). P2Y2 receptor 
has been the potential therapeutic target in treating individuals with cystic fibrosis 
(Mason et al, 1991). Until recently, multiple P2Y subtypes have been identified and 
widely implicated in CP secretion in airway epithelium (Knowles et al, 1991; 
Communi et al, 1999). Among these, P2Y6 receptors maybe of particular interest. 
First, the studies on the functional role of P2Y6 receptors in airway epithelium 
remain controversial. For example, some studies have reported the presence of P2Y6 
receptors in 16HBE14o- cells (Communi et al, 1999; Wolff et al, 2005) and mouse 
trachea (Schreiber & Kunzelmann, 2005); besides, UDP was shown to potently 
stimulate CI" secretion in human nasal epithelial cells (Lazarowski et al, 1997). On 
the contrary, other studies showed that the addition of P2Y6 receptor agonist (UDP) 
had no effect on ion transport in distal bronchi (Inglis et al, 1999) and Calu-3 cells 
(Son et al, 2004). Thus, the contribution of P2Y6 receptors to the regulation of 
electrolyte transport in the airways remains to be proven unambiguously. Second, it is 
suggested pyrimidine nucleotides (UTP, UDP) are more preferable therapeutic agents 
in treating cystic fibrosis, since they are not degraded to adenosine which induces 
bronchoconstriction (Communi et al, 1999; Schreiber & Kunzelmann, 2005). UDP is 
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of particularly high therapeutic value as it is more stable than UTP. This is because 
UTP is hydrolyzed at a 2- to 3-fold faster rate than UDP in human airway tissue 
(Lazarowski et al, 1997). Third, data from previous section showed that UDP exerted 
different effects on Isc and [Ca2+], in 16HBE14o- cells when compared with ATP and 
UTP. This suggests that other signaling pathways or molecules might be involved in 
the stimulation of Isc by UDP. The role of P2Y6 receptor on the regulation of ion 
transport would be of special interest. Thus, in our present study, we would like to 
investigate the effect of UDP, which is a potent, selective and stable agonist of P2Y6 
receptor, on CI" secretion in 16HBE14o- cells. Our previous quantitative real-time 
PCR data demonstrated the expression of mRNA coding for P2Yi, P2Y2, P2Y4 and 
P2Y6 receptor subtypes in 16HBE14o- cells (Wong et al, 2006). This is consistent 
with previous studies reporting that P2Y6 receptors were expressed and functionally 
active on both apical and basolateral sides in 16HBE14o- cells (Communi et al, 1999; 
Schreiber & Kunzelmann, 2005), confirming the existence of P2Y6 receptors in 
16HBE140- cells. 
To avoid the effects of UTP contamination and to ensure that any observed 
effects were not due to the conversion of UDP to UTP, UDP was incubated in normal 
KH solution containing hexokinase (100 U/ml) and 22 mM D-glucose to remove any 
contaminating nucleotide triphosphates for 1 h at 37°C. In the presence of glucose, 
hexokinase transfers the y-phosphate of UTP to glucose, producing UDP and 
glucose-6-phospahte as products (Lazarowski et al” 1997). 
Data shows that apical UDP stimulated a more pronounced increase in Isc than 
basolateral UDP, while both apical and basolateral UDP evoked almost the same level 
of increase in [Ca2+], (Fig. 3.2.1.1, A and B). The asymmetry of the effects of apical 
and basolateral UDP in 16HBE14o- cells suggests different regulatory pathways for 
Cr secretion are mediated by apical and basolateral P2Y6 receptors. 
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In general, transepithelial CI" secretion occurring in airway epithelial cells is 
mainly dependent on two types of ion channels, apical CI" channels and basolateral K+ 
channels (Welsh, 1987). CI" exits across apical membrane via CI" channels. It is well 
known that apical CI" channels can be regulated by intracellular cAMP and Ca^ "". 
These CI" channels mainly include CFTR, which is a cAMP-activated CI" channel 
(Cheng et al, 1991) and CaCC, which is a Ca^^ -activated CI" channel (Wagner et al, 
1991). c r secretion also requires the activation of K+ channels located at the 
basolateral membrane. The efflux of K+ through basolateral K+ channels is important 
in hyperpolarizing the cells, thus maintaining the driving force for apical CI" exit. Two 
different types of K+ channels have been widely described, including cAMP- and 
Ca^^ -dependent K+ channels in the basolateral membrane of secretory epithelial cells 
(Mall et al, 2000; Bernard et al, 2003). In our present study, various CI" and K+ 
channel blockers were used to elucidate the ionic mechanism underlying the effects of 
apical and basolateral UDP in 16HBE14o- cells. Since the presence of channel 
blockers might reduce the duration of the agonist-induced response but not the peak 
magnitude of the Isc response, the area under the Isc response curve, i.e. the total 
charge transfer across the epithelia was also plotted additionally for comparison. 
Studies by Fong et al (1998) suggested that it would be much more informative and 
appropriate to compare the mean total charge transfer across the epithelium, than to 
compare the peak amplitude of the Isc response. Thus, in our experiments, the 
contributions of different apical CI" channels and basolateral K+ channels in regulation 
of c r secretion were mainly assessed by the mean total charge transfer across the 
epithelia. 
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4.2.1 Possible ionic mechanism for chloride secretion mediated by apical P2Y6 
receptors 
First, the effect of apical UDP was examined, with the pretreatment of various 
apical c r channel blockers. The Isc evoked by apical UDP was insensitive to the 
CFTR blocker glibenclamide (Fig. 3.2.2.2 and 3.2.2.3). This finding differs from that 
of Schreiber & Kunzelmann (2005) who reported the inhibitory effect of 
glibenclamide on Isc induced by apical UDP. The reason for this discrepancy may be 
due to the non-specific inhibition by glibenclamide for CFTR (Rabe et al, 1995). 
Some studies have reported that glibenclamide may block ATP-sensitive K+ channels 
(Light & French, 1994; Teramoto et al, 2004). Therefore, CFTRinh-172, which is a 
more specific CFTR blocker (Thiagarajah et al, 2004)，was used instead. 
CFTRinh-172 reduced the Isc (Fig. 3.2.2.5 and 3.2.2.6)，suggesting that CFTR was 
activated due to the stimulation by apical UDP. Cozens et al. (1994) has reported the 
expression of CFTR in 16HBE14o- cells which could mediate CI" secretion stimulated 
by cAMP-elevating agents such as isoproterenol and forskolin. Moreover, DIDS, an 
inhibitor that selectively blocks CaCC (Anderson et al, 1992), nearly abolished the 
effect of apical UDP on Isc (Fig. 3.2.2.8 and 3.2.2.9)，indicating that CaCC was also 
involved. 
Second, the involvement of basolateral K+ channels upon the stimulation of 
apical P2Y6 receptors was evaluated, with the pretreatment of various basolateral K+ 
channel blockers. Chromanol 293B, a specific cAMP-dependent K+ channel blocker 
(Mall et al., 2000)，had no effect on Isc in response to apical UDP (Fig. 3.2.3.2 and 
3.2.3.3). In contrast，in the presence of clotrimazole, a blocker of intermediate-
conductance Ca2+-activated K+ channels (IKCal) (Ishii et al, 1997)，apical UDP-
induced Isc was reduced (Fig. 3.2.3.5 and 3.2.3.6). TRAM-34, a more potent and 
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selective IKCal channel blocker (Wulff et al, 2001), also had an inhibitory effect on 
Isc evoked by apical UDP (Fig. 3.2.3.9). These data address a role of Ca '^^ -activated 
K+ channels, but not cAMP-dependent K+ channels in the control of CI" secretion 
mediated by apical P2Y6 receptors. IKCal channels are involved in CI" secretion by 
generating a favorable electrochemical gradient, and thus increasing the driving force 
for Cr exit. The expression of IKCal channels has been demonstrated in 16HBE14o-
cells (Bernard et al, 2003)，Calu-3 cells (Szkotak et al, 2004) and H441 distal airway 
epithelial cells (Wilson et al, 2006). 
Taken together, these findings imply that apical P2Y6 receptors may be 
coupled to both cAMP- and Ca^ -^dependent pathways in 16HBE14o- cells, similar to 
that observed in rat colonic crypts (Kottgen et al, 2003) as well as mouse trachea 
(Schreiber & Kunzelmann，2005). Following the apical application of UDP, a parallel 
increase of intracellular cAMP and Ca^ "^  mediated by apical P2Y6 receptors is 
suggested. The increase in intracellular cAMP only activates apical CFTR but not 
basolateral cAMP-dependent K+ channels. The cAMP signaling induced by apical 
P2Y6 receptors appears to be confined to the apical membrane. On the other hand, the 
increase in intracellular Ca^ ^ activates both apical Ca^^ -activated CI" channels and 
basolateral Ca^ -^activated K+ channels. 
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4.2.2 Possible ionic mechanism for chloride secretion mediated by basolateral P2Y6 
receptors 
To elucidate the possible ionic mechanism underlying the regulation of CI" 
secretion by basolateral P2Y6 receptors stimulation, similar experimental protocols 
were used as described in the previous section. The Isc response evoked by 
basolateral UDP was studied, in the presence of various apical CI" or basolateral K+ 
channel blockers. Conversely to apical UDP, glibenclamide showed an inhibitory 
effect on Isc induced by basolateral UDP (Fig. 3.2.2.11 and 3.2.2.12). However, 
CFTRinh-172 failed to block the basolateral UDP evoked-Zsc (Fig. 3.2.2.14 and 
3.2.2.15). Since CFTRinh-172 is a more specific blocker for CFTR, it is more likely 
that the implication of CFTR in the basolateral UDP evoked-Zyc might be ruled out. 
This Isc was completely abolished in the presence of DIDS (Fig. 3.2.2.17 and 
3.2.2.18), suggesting the involvement of CaCC under the effect of basolateral UDP. 
On the other hand, basolateral UDP-induced Isc was not sensitive to 
chromanol 293B (Fig. 3.2.3.11 and 3.2.3.12), ruling out the possible involvement of 
cAMP-dependent KT channels. In contrast, this Isc was significantly reduced by 
clotrimazole (Fig. 3.2.3.14 and 3.2.3.15). Similar inhibitory effect on Isc in response 
to basolateral UDP was also observed when a more specific IKCal channel blocker, 
TRAM-34, was applied (Fig. 3.2.3.17 and 3.2.3.18). This obviously suggests the 
activation of Ca '^^ -activated K+ channels upon the stimulation of basolateral P2Y6 
receptors by UDP. 
Taken together, the basolateral UDP-induced Isc was sensitive to DIDS, 
clotrimazole and TRAM-34, but not to CFTRinh-172 and chromanol 293B, indicating 
that the regulation of chloride secretion mediated by basolateral P2Y6 receptors relies 
only on apical Ca "^^ -activated CI" channels and basolateral Ca^^ -activated K+ channels. 
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In other words, basolateral P2Y6 receptors may be coupled to Ca^ -^dependent 
pathway but not cAMP-dependent pathway. The activation of basolateral P2Y6 
receptors by UDP increases intracellular Ca^ "^ , which in turn activates apical 
Ca^ -^activated CI" channels as well as basolateral Ca^^ -activated K+ channels in 
16HBE140- cells. These findings are consistent with a previous report indicated that 
basolateral P2Y6 receptors are coupled to intracellular Ca^ ^ but not cAMP in mouse 
trachea (Schreiber & Kunzelmann, 2005). 
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4.3 Involvement of other possible signaling molecules or pathway underlying the 
action of apical and basolateral UDP 
As suggested in previous section, apical P2Y6 receptor stimulation might 
increase the intracellular cAMP by which apical CFTR is activated via protein kinase 
A (PKA)-dependent mechanisms (Berger et al, 1991). However, studies by Palmer et 
al. (2006) pointed out that the activation of CFTR may not be a consequence of 
increased intracellular cAMP and subsequent PKA activation of CFTR. Meanwhile, 
protein kinase C (PKC)-dependent phosphorylation of CFTR was being addressed. A 
previous study has reported that extracellular nucleotides regulate CI" secretion in 
human nasal epithelial cells through PKC-dependent activation of CFTR (Paradiso et 
al, 2001) while Button et al (2001) identified a PKC phosphorylation site critical for 
PKC activation of CFTR. In order to determine whether the activation of CFTR was 
dependent on the increase in intracellular cAMP or on the stimulation of PKC in a 
manner that was independent of the increase in intracellular cAMP, PepTag® 
non-radioactive cAMP-dependent protein kinase assay system as well as PKC 
inhibitors were employed to elucidate the role of PKA and PKC in the activation of 
CFTR. 
First，the effect of apical and basolateral UDP on PKA activity was measured 
in 16HBE140- cells using PepTag® non-radioactive cAMP-dependent protein kinase 
assay system that measures the phosphorylation of Kemptide (Leu-Arg-Arg-Ala-Ser-
Leu-Gly), a synthetic substrate specific for PKA. As shown in Fig. 3.3.1.1，PKA, 
which is downstream of cAMP in the signaling pathway, was activated by apical UDP. 
Additionally, as indicated in section 4.2.1，apical UDP activates cAMP-dependent 
apical CFTR but not basolateral K+ channels. It is therefore most likely that the apical 
UDP-induced Isc was mediated by the increase in intracellular cAMP，which then 
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activates PKA and subsequently lead to the opening of apical cAMP-dependent CI' 
channels, CFTR. This provides another piece of evidence that apical P2Y6 receptor 
may be coupled to cAMP-PKA-dependent pathway, in addition to Ca^ -^dependent 
pathway. Furthermore, these findings showed that 16HBE14o- cells appear to be able 
to functionally confine cAMP-regulated signaling to the apical cell membrane 
ipsilateral to P2Y receptor stimulation. On the other hand, basolateral UDP was also 
shown to increase PKA activity (Fig. 3.3.1.1). However, the findings described in 
section 4.2.2 suggest that the basolateral UDP stimulation relies only on 
Ca2+-activated apical CI" and basolateral K+ channels, without the involvement of 
cAMP-activated apical CI" as well as basolateral K+ channels. The reason for this 
inconsistency remains to be elucidated. It is speculated that cAMP signaling appears 
to be compartmentalized in 16HBE14o- cells, with basolaterally released cAMP 
failing to activate CFTR. In Calu-3 cells, apical adenosine A2B receptors are coupled 
to cAMP pathway. Barnes et al (2005) suggested the presence of phosphodiesterases 
to form a diffusion barrier that confine cAMP signaling to apical subcellular domains, 
at which CFTR is located. Another study demonstrated that cAMP-dependent 
activation of CFTR requires colocally anchored PKA (Huang et al, 2000). Therefore, 
activation of basolateral P2Y6 receptors could not functionally coupled to the 
activation of CFTR. The other possibility is that PKA may not be a signaling 
molecule that is solely responsible for the activation of cAMP-dependent ion channels. 
In comparison to cAMP, Ca^ ^ ion seems to be a more "global" or "diffusible" second 
messenger in the present study by which both apical CaCC and basolateral IKCal 
channels could be activated upon either apical or basolateral P2Y6 receptors-mediated 
[Ca2+], increase. 
Second, to study the role of PKC in the activation of CFTR elicited by apical 
and basolateral UDP in 16HBE14o- cells，the effect of PKC inhibitors on Isc in 
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response to apical and basolateral UDP was examined. H-7, which is a nonspecific 
PKC inhibitor (Nixon et al, 1991), reduced the apical UDP-induced Isc (Fig. 3.3.2.1 
and 3.3.2.2). Conversely, this Isc was insensitive to another PKC inhibitor, 
GF109203X (Fig. 3.3.2.4). Since H-7 has been reported to potentially block PKA 
activity as well in vitro (Hardie, 1993) and meanwhile GF109203x is a more specific 
but broad spectrum inhibitor of PKC isozymes (Toullec et al, 1991), it is most likely 
that PKC activation may not be involved in mediating the apical UDP effect. Similarly, 
basolateral UDP-evoked Isc was insensitive to both H-7 and GF109203x (Fig. 
3.3.2.5 - Fig. 3.3.2.8). PKC is also not involved in mediating the basolateral effect of 
UDP on Isc. 
Taken together, the possible involvement of the PKC pathway in regulating CI" 
secretion in 16HBE14o- cells could be ruled out. Specifically, it appears that the 
apical CFTR are activated via a cAMP-PKA-dependent pathway, but not by the 
stimulation of PKC in a manner that was independent of the increase in intracellular 
cAMR Additionally, since the [Ca^ "^ ], increase induced by basolateral UDP had no 
effect on CFTR, as shown by the insensitivity of basolateral UDP-evoked Isc towards 
CFTRinh-172, this suggests that Ca^ ^ ions would unlikely be involved in the 
regulation of CFTR activity. 
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4.4 Summary 
Overall, 16HBE14o- epithelia expressed at least four P2Y receptor subtypes, 
namely P2Yi, P2Y2, P2Y4 and P2Y6 receptors. 16HBE14o- cells possess functional 
P2Y6 receptors on both apical and basolateral cell membranes, at which when 
activated by UDP, the apical and basolateral P2Y6 receptors elicits asymmetric 
patterns of CI" secretion via different regulatory pathways. Presumably, upon UDP 
stimulation, apical P2Y6 receptors are coupled to both cAMP- and Ca^ "^ -dependent 
pathways, thereby leading to the activation of apical CFTR, CaCC and basolateral 
IKCal channels while basolateral P2Y6 receptors are coupled to Ca^ -^ but not 
cAMP-dependent pathway, activating only apical CaCC and basolateral IKCal 
channels but not cAMP-dependent CFTR and K+ channels. A hypothesized schematic 
diagram of the signaling pathways involved in CI" secretion mediated by apical and 
basolateral P2Y6 receptors is illustrated in Fig. 4.1. 
The effect of sidedness was observed upon activation of apical and basolateral 
P2Y6 receptors，suggesting that UDP may have divergent effects on CI" secretion 
depending on the side of addition. Besides, it is noteworthy that UDP is a more stable 
therapeutic agent than ATP and UTP (Lazarowski et al, 1997). Together with the 
parallel activation of both cAMP and Ca^ ^ signaling pathways (Schreiber & 
Kunzelmann, 2005), P2Y6 receptors would be of therapeutic interest in cystic fibrosis 
in causing a more powerful and longer lasting activation of CI" secretion in the 
airways, in addition to the well known-P2Y2 receptors. 
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Figure 4.1 A hypothesized scheme of signaling pathways of ion transport 
mediated by apical and basolateral P2Y6 receptors in 16HBE14o- cells. P2Y6-R 
(P2Y6 receptor); Gq (heterotrimeric GTP-binding protein); PLC (phospholipase C); 
IP3 (inositol 1,4,5-triphosphate); Ca^ ^ (intracellular Ca^ "^ ); AC (adenylate cyclase); 
PKA (protein kinase A); CFTR (cystic fibrosis transmembrane conductance 
regulator); CaCC (Ca^^-activated CI" channel); IKCal (intermediate-conductance 
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